|
(Mark One)
|
|
þ
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the fiscal year ended September 30, 2018
|
OR
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from
to
|
Delaware
|
|
94-3156479
|
(State or Other Jurisdiction of
|
|
(I.R.S. Employer
|
Incorporation or Organization)
|
|
Identification No.)
|
|
|
|
1 Wayside Road
Burlington, Massachusetts
|
|
01803
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Title of Each Class
|
|
Name of Each Exchange on Which Registered
|
Common stock, $0.001 par value
|
|
Nasdaq Stock Market LLC
|
Preferred share purchase rights
|
|
Nasdaq Stock Market LLC
|
|
Large accelerated filer
þ
|
|
Accelerated filer
o
|
Smaller reporting company
o
|
|
Non-accelerated filer
o
|
|
Emerging growth company
o
|
|
|
|
|
Page
|
PART I
|
||
Item 1.
|
||
Item 1A.
|
||
Item 1B.
|
||
Item 2.
|
||
Item 3.
|
||
Item 4.
|
||
|
||
PART II
|
||
Item 5.
|
||
Item 6.
|
||
Item 7.
|
||
Item 7A.
|
||
Item 8.
|
||
Item 9.
|
||
Item 9A.
|
||
Item 9B.
|
||
|
||
PART III
|
||
Item 10.
|
||
Item 11.
|
||
Item 12.
|
||
Item 13.
|
||
Item 14.
|
||
|
||
PART IV
|
||
Item 15.
|
•
|
Focus on opportunities that leverage our core strengths in key vertical markets.
During the third quarter of fiscal year 2018, we commenced a comprehensive portfolio and business review with the goal to improve long-term shareholder return and operational efficiency. We are moving toward a goal of a simplified and more efficient operational structure, capable of sustainable, long-term revenue and earnings growth, with resources keenly focused on opportunities that leverage our core strengths in key vertical markets. We plan to focus our resources and R&D capabilities on our core capabilities and shift our focus away from non-core businesses and solutions.
|
•
|
Maintain global leadership in all of our major markets and solutions areas.
We have historically targeted markets where we benefit from strong technology, sales and vertical market differentiation. Today, we are one of the leading providers of voice recognition and NLU. We invest considerable time and resources to ensure that we maintain this position through customer satisfaction, technology leadership, deep domain experience and market specialization.
|
•
|
Maintain depth in technology, solutions, and intellectual property portfolio.
We have built a world-class portfolio of technologies, applications, solutions and intellectual property through both internal development and acquisitions. We expect to continue to pursue opportunities to expand our assets, geographic presence, distribution network and customer base through organic growth and strategic transactions. We continue to strengthen our core technologies in voice and language, and expand our offerings through research and innovations in AI, including cognitive computing and machine learning.
|
•
|
Continue to expand our extensive network of global operations, distribution and services networks
.
We market and sell our solutions and technologies directly through a dedicated sales force and through a global network of resellers, including system integrators, independent software vendors, value-added resellers, distributors, hardware vendors, and telecommunications carriers and e-commerce websites. In addition, we continue to expand our presence within our markets, such as ambulatory markets in our Healthcare segment and omni-channel customer services in our Enterprise segment, and we have expanded initiatives in geographic markets such as China, Latin America and Southeast Asia.
|
•
|
Continue to expand hosting and transaction-based offerings.
We remain focused on increasing our hosting and transaction-based offerings. We generate hosting revenues through on-demand models that typically have multi-year terms with pricing based on volume of usage, number of transactions, number of seats or number of devices. This pricing structure allows customers to use our products at a lower initial cost when compared to the sale of a perpetual license. This will enable us to deliver applications that our customers use, and pay for, on a recurring basis, providing us with the opportunity to benefit from recurring revenue streams.
|
•
|
Maintain significant presence and customer preference in our markets.
We specialize in creating large, enterprise-class solutions that are used by many of the world’s largest companies. By combining our core technology, professional services, local presence and deep domain experience, we are able to deliver these specialized offerings for our customers and partners. We have established a trusted position in numerous markets and today work with a majority of the Fortune 100 companies.
|
•
|
Strengthen financial profile with improvement in revenue, earnings per share, margin, and cash flow.
We are focused on improving our financial performance by executing upon identified strategic initiatives and further evolving our business toward recurring revenue models, which are positioning us for increased future revenue and profitability growth. Recurring revenue represented
71.4%
,
72.5%
and 69.6% of total revenue in fiscal years
2018
,
2017
and 2016, respectively.
|
•
|
Dragon Medical:
Provide dictation capabilities that empower physicians to accurately capture and document patient care in real-time from many devices and without disrupting existing work flows. We have expanded this solution to provide clinical language understanding and cognitive intelligence that delivers real-time queries to physicians at the point of care, producing measurable clinical, financial and compliance outcomes.
|
•
|
Transcription solutions
:
Enable physicians in larger and mid-sized healthcare enterprises to streamline clinical documentation with an on-demand, enterprise-wide medical transcription platforms, and allow healthcare organizations to outsource transcription services. Our transcription solutions are generally offered as an on-demand model.
|
•
|
Clinical document improvement and coding solutions
:
Ensure patient health information is properly documented, coded, and evaluated to provide more complete and accurate clinical documentation. These services and offerings assist organizations with regulatory compliance and coding efficiency to receive appropriate and timely reimbursement and improve quality reporting. The solutions are generally sold under a term licensing model.
|
•
|
Diagnostic solutions
:
Allow radiologists to easily document, collaborate, and share medical images and reports in order to optimize patient care
.
These solutions are generally sold under a traditional perpetual license model, but they are transitioning rapidly to term licensing and transaction based models.
|
•
|
Dragon solutions
:
Provide professional and personal productivity solutions to business users and consumers with the ability to use their voice to create content, reports and other documents, as well as control their computers and laptops without the use of a keyboard or mouse. This dictation capability is similar to Dragon Medical and is used in markets such as law, public safety, social services, education and accessibility. Dragon solutions are sold generally through a traditional perpetual software license model, and we have recently introduced an on-demand model.
|
•
|
On-Premise solutions and services
:
Provide software that is leveraged to implement automated customer service solutions that are integrated with a wide range of on-premise third-party IVR and contact center platforms. Our products and technologies include ASR, voice biometrics, transcription, TTS, dialog and analytics. Our global professional services team leverages domain expertise to provide end-to-end services to customers and partners, including business consulting, design, development, and deployment of integrated solutions. Our on-premise licensed products are primarily sold through a traditional perpetual software license model, and our on-premise professional services are sold under project-based and multi-year managed services contracts.
|
•
|
On-Demand multichannel cloud:
Deliver a platform that provides enterprises with the ability to implement automatic customer service across inbound, outbound, and digital customer service channels in the cloud. Our on-demand multichannel cloud leverages our ASR, voice biometrics, TTS, and virtual assistant technologies, to implement intelligent, conversational self-service applications, including voice call steering and self-service, automated verification, account access, virtual chat, proactive SMS, messaging and email, and customer service for mobile device customers. In addition, our acquisition of TouchCommerce, Inc. in fiscal year 2016 allows us to provide an end-to-end engagement platform that merges intelligent self-service with assisted service to increase customer satisfaction, strengthen customer loyalty and improve business results. Our on-demand multichannel cloud is sold through sales models that typically have multi-year terms with pricing based on the channel provided and/or volume of usage.
|
•
|
MFP Scan and capture automation solutions
:
Deliver scanning and document management solutions that improve productivity, drive efficiency and assist in enhancing security.
|
•
|
MFP Print management and automation solutions
:
Offer printing and document management solutions to capture and automate paper to digital work flows to increase efficiency
.
|
•
|
PDF and OCR software
:
Provide intuitive technologies that enable the efficient capture, creation, and management of document work flows.
|
•
|
Specialized Professional Services.
Our superior technology, when coupled with the high quality and domain knowledge of our professional services organization, allows our customers and partners to place a high degree of confidence and trust in our ability to deliver results. We support our customers in designing and building powerful innovative solutions that specifically address their needs and requirements.
|
•
|
International Coverage.
The international reach of our solutions and technologies is due to the broad language coverage of our offerings, including our ASR and NLU solutions, which provide recognition for approximately
70
languages and dialects and natural-sounding synthesized speech in over
160
voices, and support a broad range of hardware platforms and operating systems. Our imaging technology supports more than
120
languages for OCR and document handling, with up to
20
screen language choices, including Asian languages.
|
•
|
Technological Superiority.
Our ASR, NLU and imaging technologies, applications and solutions are often recognized as the most innovative and proficient in their respective categories. Our ASR and NLU solutions have industry-leading recognition accuracy and provide a natural, voice-enabled interaction with systems, devices and applications. Our OCR technology in our Imaging segment is viewed as the most accurate in the industry. Technology publications, analyst research and independent benchmarks have consistently indicated that our solutions and technologies rank at or above performance levels of alternative solutions.
|
•
|
Broad Distribution Channels.
Our ability to address the needs of specific markets, such as financial, law, healthcare and government, and to introduce new solutions and technologies quickly and effectively is provided by our direct sales force, our extensive global network of resellers, comprising system integrators, independent software vendors, value-added resellers, hardware vendors, telecommunications carriers and distributors, and our e-commerce website.
|
•
|
volume, timing and fulfillment of customer orders and receipt of royalty reports;
|
•
|
fluctuating sales by our channel partners to their customers;
|
•
|
customers delaying their purchasing decisions in anticipation of new versions of our products;
|
•
|
contractual counterparties failing to meet their contractual commitments to us;
|
•
|
introduction of new products by us or our competitors;
|
•
|
cybersecurity or data breaches;
|
•
|
seasonality in purchasing patterns of our customers;
|
•
|
reduction in the prices of our products in response to competition, market conditions or contractual obligations;
|
•
|
returns and allowance charges in excess of accrued amounts;
|
•
|
timing of significant marketing and sales promotions;
|
•
|
impairment of goodwill or intangible assets;
|
•
|
the pace of the transition to an on-demand and transactional revenue model;
|
•
|
delayed realization of synergies resulting from our acquisitions;
|
•
|
accounts receivable that are not collectible and write-offs of excess or obsolete inventory;
|
•
|
increased expenditures incurred pursuing new product or market opportunities;
|
•
|
higher than anticipated costs related to fixed-price contracts with our customers;
|
•
|
change in costs due to regulatory or trade restrictions;
|
•
|
expenses incurred in litigation matters, whether initiated by us or brought by third-parties against us, and settlements or judgments we are required to pay in connection with disputes; and
|
•
|
general economic trends as they affect the customer bases into which we sell.
|
•
|
adverse political and economic conditions, or changes to such conditions, in a specific region or country;
|
•
|
trade protection measures, including tariffs and import/export controls, imposed by the United States and/or by other countries or regional authorities such as China, Canada or the European Union;
|
•
|
the impact on local and global economies of the United Kingdom leaving the European Union;
|
•
|
changes in foreign currency exchange rates or the lack of ability to hedge certain foreign currencies;
|
•
|
compliance with laws and regulations in many countries and any subsequent changes in such laws and regulations;
|
•
|
geopolitical turmoil, including terrorism and war;
|
•
|
changing data privacy regulations and customer requirements to locate data centers in certain jurisdictions;
|
•
|
evolving restrictions on cross-border investment, including recent enhancements to the oversight by the Committee on Foreign Investment in the United States pursuant to the Foreign Investment Risk Preview Modernization Act and substantial restrictions on investment from China;
|
•
|
changes in applicable tax laws;
|
•
|
difficulties in staffing and managing operations in multiple locations in many countries;
|
•
|
longer payment cycles of foreign customers and timing of collections in foreign jurisdictions; and
|
•
|
less effective protection of intellectual property than in the United States.
|
•
|
loss of revenue resulting from the operational disruption;
|
•
|
loss of revenue or increased bad debt expense due to the inability to invoice properly or to customer dissatisfaction resulting in collection issues;
|
•
|
loss of revenue due to loss of customers;
|
•
|
material remediation costs to restore systems;
|
•
|
material investments in new or enhanced systems in order to enhance our information security posture;
|
•
|
cost of incentives offered to customers to restore confidence and maintain business relationships;
|
•
|
reputational damage resulting in the failure to retain or attract customers;
|
•
|
costs associated with potential litigation or governmental investigations;
|
•
|
costs associated with any required notices of a data breach;
|
•
|
costs associated with the potential loss of critical business data; and
|
•
|
other consequences of which we are not currently aware but will discover through the remediation process.
|
•
|
cause our customers to lose confidence in our solutions;
|
•
|
harm our reputation;
|
•
|
expose us to litigation, regulatory investigations and to resulting liabilities including reimbursement of customer costs, damages penalties or fines imposed by regulatory agencies; and
|
•
|
require us to incur significant expenses for remediation.
|
•
|
difficulty in transitioning and integrating the operations and personnel of the acquired businesses;
|
•
|
difficulty in separating the operations, personnel and systems of divested businesses:
|
•
|
potential disruption of our ongoing business and distraction of management;
|
•
|
difficulty in incorporating acquired products and technologies into our products and technologies;
|
•
|
potential difficulties in completing projects associated with in-process research and development;
|
•
|
unanticipated expenses and delays in completing acquired development projects and technology integration and upgrades;
|
•
|
challenges associated with managing additional, geographically remote businesses;
|
•
|
impairment of relationships with partners and customers;
|
•
|
assumption of unknown material liabilities of acquired companies;
|
•
|
the accuracy of revenue and bookings projections of acquired companies;
|
•
|
customers delaying purchases of our products pending resolution of product integration between our existing and our newly acquired products;
|
•
|
entering markets or types of businesses in which we have limited experience; and
|
•
|
potential loss of key employees of the acquired business.
|
•
|
costs incurred to integrate the operations of businesses we acquire, such as transitional employee expenses and employee retention, redeployment or relocation expenses;
|
•
|
impairment of goodwill or intangible assets;
|
•
|
amortization of intangible assets acquired;
|
•
|
a reduction in the useful lives of intangible assets acquired;
|
•
|
identification of or changes to assumed contingent liabilities, both income tax and non-income tax related, after our final determination of the amounts for these contingencies or the conclusion of the measurement period (generally up to one year from the acquisition date), whichever comes first;
|
•
|
charges to our operating results to eliminate certain duplicative pre-merger activities, to restructure our operations or to reduce our cost structure;
|
•
|
charges to our operating results arising from expenses incurred to effect the acquisition; and
|
•
|
charges to our operating results due to the expensing of stock awards assumed in acquisitions.
|
•
|
significant adjustments to our multi year operating plans, in connection of our ongoing portfolio review;
|
•
|
changes in our organization or management reporting structure that could result in additional reporting units, which may require alternative methods of estimating fair values or greater disaggregation or aggregation in our analysis by reporting unit;
|
•
|
significant under performance relative to historical or projected future operating results;
|
•
|
significant changes in the manner of or use of the acquired assets or the strategy for our overall business;
|
•
|
significant negative industry or economic trends;
|
•
|
significant decline in our stock price for a sustained period; and
|
•
|
our market capitalization declining to below net book value.
|
•
|
projected levels of taxable income;
|
•
|
pre-tax income being lower than anticipated in countries with lower statutory rates or higher than anticipated in countries with higher statutory rates;
|
•
|
increases or decreases to valuation allowances recorded against deferred tax assets;
|
•
|
tax audits conducted and settled by various tax authorities;
|
•
|
adjustments to income taxes upon finalization of income tax returns;
|
•
|
the ability to claim foreign tax credits;
|
•
|
the repatriation of non-U.S. earnings for which we have not previously provided for income taxes; and
|
•
|
changes in tax laws and their interpretations in countries in which we are subject to taxation.
|
•
|
incur additional debt or issue guarantees;
|
•
|
create liens;
|
•
|
make certain investments;
|
•
|
enter into transactions with our affiliates;
|
•
|
sell certain assets;
|
•
|
repurchase capital stock or make other restricted payments;
|
•
|
declare or pay dividends or make other distributions to stockholders; and
|
•
|
merge or consolidate with any entity.
|
•
|
require us to use a large portion of our cash flow to pay principal and interest on debt, including the convertible debentures and the credit facility, which will reduce the availability of our cash flow to fund working capital, capital expenditures, acquisitions, research and development, exploiting business opportunities, and other business activities;
|
•
|
place us at a competitive disadvantage compared to our competitors that have less debt; and
|
•
|
limit, along with the financial and other restrictive covenants related to our debt, our ability to borrow additional funds, dispose of assets or pay cash dividends.
|
Item 1B.
|
Unresolved Staff Comments
|
Item 2.
|
Properties
|
Item 3.
|
Legal Proceedings
|
Item 4.
|
Mine Safety Disclosures
|
|
Low
|
|
High
|
||||
Fiscal Year 2017:
|
|
|
|
|
|
||
First quarter
|
$
|
13.44
|
|
|
$
|
17.47
|
|
Second quarter
|
$
|
14.85
|
|
|
$
|
17.43
|
|
Third quarter
|
$
|
16.36
|
|
|
$
|
19.93
|
|
Fourth quarter
|
$
|
15.38
|
|
|
$
|
17.97
|
|
Fiscal Year 2018:
|
|
|
|
|
|
||
First quarter
|
$
|
14.02
|
|
|
$
|
17.72
|
|
Second quarter
|
$
|
15.23
|
|
|
$
|
18.75
|
|
Third quarter
|
$
|
12.18
|
|
|
$
|
15.75
|
|
Fourth quarter
|
$
|
13.70
|
|
|
$
|
17.42
|
|
|
|
9/13
|
9/14
|
9/15
|
9/16
|
9/17
|
9/18
|
|
|
|
|
|
|
|
|
Nuance Communications, Inc.
|
|
100.00
|
82.52
|
87.63
|
77.62
|
84.15
|
92.72
|
Russell 2000
|
|
100.00
|
103.93
|
105.23
|
121.50
|
146.70
|
169.06
|
S&P Information Technology
|
|
100.00
|
129.27
|
132.00
|
162.13
|
208.96
|
274.76
|
S&P Software & Services Select
|
100.00
|
103.86
|
114.06
|
136.40
|
162.94
|
226.49
|
Period
|
|
Total Number of Shares Purchased
|
|
Average Price Paid per Share
|
|
Total Number of Shares Purchased as Part of Publicly Announced Program
(1)
|
|
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program
(1)
|
||||||
July 1, 2018 - July 31, 2018
|
|
907,286
|
|
|
$
|
14.45
|
|
|
907,286
|
|
|
$
|
68,324,001
|
|
August 1, 2018 - August 31, 2018
|
|
402,897
|
|
|
$
|
15.78
|
|
|
402,897
|
|
|
$
|
561,968,153
|
|
September 1, 2018 - September 30, 2018
|
|
280,213
|
|
|
$
|
16.59
|
|
|
280,213
|
|
|
$
|
557,318,776
|
|
Total
|
|
1,590,396
|
|
|
|
|
1,590,396
|
|
|
|
|
Fiscal Year Ended September 30,
|
||||||||||||||||||
(In millions, except per share amounts)
|
2018
|
|
2017
|
|
2016
|
|
2015
|
|
2014
|
||||||||||
Operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total revenues
|
$
|
2,051.7
|
|
|
$
|
1,939.4
|
|
|
$
|
1,948.9
|
|
|
$
|
1,931.1
|
|
|
$
|
1,923.5
|
|
Gross profit
|
$
|
1,178.1
|
|
|
$
|
1,085.6
|
|
|
$
|
1,119.4
|
|
|
$
|
1,102.6
|
|
|
$
|
1,080.9
|
|
(Loss) income from operations
|
$
|
(86.9
|
)
|
|
$
|
52.0
|
|
|
$
|
138.5
|
|
|
$
|
54.9
|
|
|
$
|
(21.4
|
)
|
(Benefit) provision for income taxes
|
$
|
(56.8
|
)
|
|
$
|
32.0
|
|
|
$
|
14.2
|
|
|
$
|
34.5
|
|
|
$
|
(4.7
|
)
|
Net loss
|
$
|
(159.9
|
)
|
|
$
|
(151.0
|
)
|
|
$
|
(12.5
|
)
|
|
$
|
(115.0
|
)
|
|
$
|
(150.3
|
)
|
Net Loss Per Share Data:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
(0.36
|
)
|
|
$
|
(0.47
|
)
|
Diluted
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
$
|
(0.04
|
)
|
|
$
|
(0.36
|
)
|
|
$
|
(0.47
|
)
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
||||||||||
Basic
|
291.3
|
|
|
289.3
|
|
|
292.1
|
|
|
317.0
|
|
|
316.9
|
|
|||||
Diluted
|
291.3
|
|
|
289.3
|
|
|
292.1
|
|
|
317.0
|
|
|
316.9
|
|
|||||
Financial Position:
|
|
|
|
|
|
|
|
|
|
||||||||||
Cash and cash equivalents and marketable securities
|
$
|
473.5
|
|
|
$
|
874.1
|
|
|
$
|
608.1
|
|
|
$
|
568.8
|
|
|
$
|
588.2
|
|
Total assets
|
$
|
5,302.4
|
|
|
$
|
5,931.9
|
|
|
$
|
5,661.5
|
|
|
$
|
5,511.9
|
|
|
$
|
5,738.2
|
|
Long-term debt
|
$
|
2,185.4
|
|
|
$
|
2,617.4
|
|
|
$
|
2,433.2
|
|
|
$
|
2,103.1
|
|
|
$
|
2,108.4
|
|
Total deferred revenue
|
$
|
873.0
|
|
|
$
|
790.0
|
|
|
$
|
736.2
|
|
|
$
|
668.2
|
|
|
$
|
548.1
|
|
Total stockholders’ equity
|
$
|
1,717.5
|
|
|
$
|
1,931.4
|
|
|
$
|
1,931.3
|
|
|
$
|
2,265.3
|
|
|
$
|
2,582.0
|
|
Selected Data and Ratios:
|
|
|
|
|
|
|
|
|
|
||||||||||
Working capital
|
$
|
164.5
|
|
|
$
|
216.4
|
|
|
$
|
347.7
|
|
|
$
|
360.2
|
|
|
$
|
466.5
|
|
Depreciation of property and equipment
|
$
|
62.4
|
|
|
$
|
55.7
|
|
|
$
|
60.6
|
|
|
$
|
62.4
|
|
|
$
|
51.7
|
|
Amortization of intangible assets
|
$
|
148.0
|
|
|
$
|
178.7
|
|
|
$
|
170.9
|
|
|
$
|
168.3
|
|
|
$
|
170.1
|
|
Gross margin percentage
|
57.4
|
%
|
|
56.0
|
%
|
|
57.4
|
%
|
|
57.1
|
%
|
|
56.2
|
%
|
•
|
Healthcare.
Customers in our healthcare segment are broadly implementing EHR systems and are working to improve clinical documentation, improve quality of care, minimize physician burnout integrate quality measures and aid reimbursement. These trends are driving a shift towards more integrated solutions that combine both Dragon Medical and transcription services, and increasingly use only Dragon Medical. Recently, higher demand for more integrated solutions have offset declines in legacy, hosted transcription services. Additionally, we have been able to capitalize on healthcare providers’ shift towards hosted, or cloud-based solutions, and away from perpetual licenses, by adding new innovations to our Dragon Medical cloud solutions including new clinical language understanding and AI capabilities designed to increase productivity and improve clinical documentation at the point of care and within existing electronic medical work flow.
|
•
|
Enterprise.
Consumer demand for 24/7, multi-channel access to customer service from the businesses they interact with is driving demand for our AI-powered omni-channel engagement solutions. We continue to enhance our technology capabilities with intelligent self-service and AI for customer service, and to extend the market for our on-demand omni-channel enterprise solutions into international markets, expand our sales and solutions for biometrics, and expand our core products and services portfolio.
|
•
|
Automotive.
Demand for our embedded and cloud-based automotive solutions is being driven by the growth in personalized, automotive virtual assistants and connected services for cars and by auto manufacturers' desire to create a branded and personalized experience, capable of intelligently integrating users' smart phone and home device preferences and technologies.
|
•
|
Imaging.
The imaging market is evolving to include more networked solutions to MFP devices, as well as more mobile access to those networked solutions, and away from packaged software. We are investing to merge the scan and print technology platforms to improve mobile access to our solutions and technologies, expand our distribution channels and embedded relationships, and expand our language coverage for OCR in order to drive a more comprehensive and compelling offering to our partners.
|
•
|
Other.
Our Other segment includes our Subscriber Revenue Services ("SRS") and Devices businesses. Our SRS business provides value-added services to mobile operators in India and Brazil (“Mobile Operator Services”) and voicemail transcription services to mobile operators in the rest of the world (“Voicemail-to-Text”). Our Devices business provides speech recognition solutions and predictive text technologies for handset devices. Our Mobile Operator Services has experienced dramatic market disruptions during fiscal year 2018. Our Devices revenue has been declining due to the ongoing consolidation of our handset manufacturer customer base and continued erosion of our penetration of the remaining market. During the fourth quarter of fiscal 2018, in connection with our comprehensive portfolio and business review efforts, we commenced a wind-down of our Devices and Mobile Operator Services businesses.
|
•
|
Total revenue
increase
d by
$112.3 million
from
$1,939.4 million
to
$2,051.7 million
;
|
•
|
Net loss
increase
d by
$8.9 million
to
$159.9 million
;
|
•
|
Gross margins
increase
d by
1.4
percentage points to
57.4%
;
|
•
|
Operating margins
decrease
d by
6.9
percentage points to
(4.2)%
;
|
•
|
Cash
provided by
operating activities for the fiscal year 2018 was $
444.4 million
,
an increase
of $
65.6 million
from fiscal year 2017.
|
•
|
Total deferred revenue increased by
10.5%
to
$873.0 million
, primarily driven by the continued growth of our Automotive connected solutions and Healthcare bundled offerings.
|
•
|
Net new bookings increased by
4.9%
from the prior fiscal year to
$1.7 billion
. The net new bookings growth benefited from strong bookings performance primarily in our Automotive and Enterprise segments.
|
•
|
Recurring revenue represented
71.4%
for fiscal year 2018 and
72.5%
for fiscal year 2017. Recurring revenue represents the sum of recurring product and licensing, hosting, and maintenance and support revenues as well as the portion of professional services revenue delivered under ongoing contracts. Recurring product and licensing revenue comprises term-based and ratable licenses as well as revenues from royalty arrangements.
|
•
|
Annualized line run-rate in our on-demand healthcare solutions decreased by
4%
from a year ago to approximately
2.8 billion
lines per year. The annualized line run-rate for the fourth quarter of fiscal year 2017 reflected the negative impact of the 2017 Malware Incident, whereas the annualized run-rate for the fourth quarter of fiscal year 2018 reflected the continued erosion of our medical transcription services. The annualized line run-rate is determined using billed equivalent line counts in a given quarter, multiplied by four.
|
•
|
Estimated three-year value of total on-demand contracts increased
5.0%
from the prior fiscal year to approximately
$2.4 billion
, primarily
by growth in our Dragon Medical cloud-based solutions and automotive connected car businesses, offset by decreases in SRS and Devices as well as the continued erosion of our medical transcription services.
We determine this value as of the end of the period reported, by using our estimate of three years of anticipated future revenue streams under signed on-demand contracts then in place, whether or not they are guaranteed through a minimum commitment clause. Our estimate is based on assumptions used in evaluating the contracts and determining sales compensation, adjusted for changes in estimated launch dates, actual volumes achieved, and other factors deemed relevant. For contracts with an expiration date beyond three years, we include only the value expected within three years. For other contracts, we assume renewal consistent with historic renewal rates unless there is a known cancellation. Contracts are generally priced by volume of usage and typically have no or low minimum commitments. Actual revenue could vary from our estimates due to factors such as cancellations, non-renewals or volume fluctuations.
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Professional services and hosting
|
$
|
1,049.4
|
|
|
$
|
976.9
|
|
|
$
|
955.3
|
|
|
7.4
|
%
|
|
2.3
|
%
|
Product and licensing
|
684.2
|
|
|
635.4
|
|
|
669.2
|
|
|
7.7
|
%
|
|
(5.1
|
)%
|
|||
Maintenance and support
|
318.0
|
|
|
327.1
|
|
|
324.3
|
|
|
(2.8
|
)%
|
|
0.9
|
%
|
|||
Total Revenues
|
$
|
2,051.7
|
|
|
$
|
1,939.4
|
|
|
$
|
1,948.9
|
|
|
5.8
|
%
|
|
(0.5
|
)%
|
|
|
|
|
|
|
|
|
|
|
||||||||
United States
|
$
|
1,470.7
|
|
|
$
|
1,352.0
|
|
|
$
|
1,385.3
|
|
|
8.8
|
%
|
|
(2.4
|
)%
|
International
|
581.0
|
|
|
587.3
|
|
|
563.6
|
|
|
(1.1
|
)%
|
|
4.2
|
%
|
|||
Total Revenues
|
$
|
2,051.7
|
|
|
$
|
1,939.4
|
|
|
$
|
1,948.9
|
|
|
5.8
|
%
|
|
(0.5
|
)%
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Professional services revenue
|
$
|
278.3
|
|
|
$
|
243.1
|
|
|
$
|
225.2
|
|
|
14.5
|
%
|
|
7.9
|
%
|
Hosting revenue
|
771.1
|
|
|
733.8
|
|
|
730.2
|
|
|
5.1
|
%
|
|
0.5
|
%
|
|||
Professional services and hosting revenue
|
$
|
1,049.4
|
|
|
$
|
976.9
|
|
|
$
|
955.3
|
|
|
7.4
|
%
|
|
2.3
|
%
|
As a percentage of total revenues
|
51.2
|
%
|
|
50.4
|
%
|
|
49.0
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Product and licensing revenue
|
$
|
684.2
|
|
|
$
|
635.4
|
|
|
$
|
669.2
|
|
|
7.7
|
%
|
|
(5.1
|
)%
|
As a percentage of total revenues
|
33.4
|
%
|
|
32.8
|
%
|
|
34.3
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Maintenance and support revenue
|
$
|
318.0
|
|
|
$
|
327.1
|
|
|
$
|
324.3
|
|
|
(2.8
|
)%
|
|
0.9
|
%
|
As a percentage of total revenues
|
15.5
|
%
|
|
16.9
|
%
|
|
16.6
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Cost of professional services and hosting revenue
|
$
|
681.5
|
|
|
$
|
660.8
|
|
|
$
|
626.2
|
|
|
3.1
|
%
|
|
5.5
|
%
|
As a percentage of professional services and hosting revenue
|
64.9
|
%
|
|
67.6
|
%
|
|
65.5
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Cost of product and licensing revenue
|
$
|
77.1
|
|
|
$
|
74.0
|
|
|
$
|
86.4
|
|
|
4.2
|
%
|
|
(14.4
|
)%
|
As a percentage of product and licensing revenue
|
11.3
|
%
|
|
11.6
|
%
|
|
12.9
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Cost of maintenance and support revenue
|
$
|
58.1
|
|
|
$
|
54.1
|
|
|
$
|
54.1
|
|
|
7.4
|
%
|
|
—
|
%
|
As a percentage of maintenance and support revenue
|
18.3
|
%
|
|
16.5
|
%
|
|
16.7
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Research and development expense
|
$
|
305.3
|
|
|
$
|
266.1
|
|
|
$
|
271.1
|
|
|
14.7
|
%
|
|
(1.8
|
)%
|
As a percentage of total revenues
|
14.9
|
%
|
|
13.7
|
%
|
|
13.9
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Sales and marketing expense
|
$
|
388.3
|
|
|
$
|
398.1
|
|
|
$
|
390.9
|
|
|
(2.5
|
)%
|
|
1.8
|
%
|
As a percentage of total revenues
|
18.9
|
%
|
|
20.5
|
%
|
|
20.1
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
General and administrative expense
|
$
|
229.8
|
|
|
$
|
166.7
|
|
|
$
|
168.5
|
|
|
37.9
|
%
|
|
(1.1
|
)%
|
As a percentage of total revenues
|
11.2
|
%
|
|
8.6
|
%
|
|
8.6
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Cost of revenues
|
$
|
56.9
|
|
|
$
|
64.9
|
|
|
$
|
62.9
|
|
|
(12.3
|
)%
|
|
3.2
|
%
|
Operating expense
|
91.1
|
|
|
113.9
|
|
|
108.0
|
|
|
(20.0
|
)%
|
|
5.5
|
%
|
|||
Total amortization expense
|
$
|
148.0
|
|
|
$
|
178.7
|
|
|
$
|
170.9
|
|
|
(17.2
|
)%
|
|
4.6
|
%
|
As a percentage of total revenues
|
7.2
|
%
|
|
9.2
|
%
|
|
8.8
|
%
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Transition and integration costs
|
$
|
16.1
|
|
|
$
|
15.2
|
|
|
$
|
6.1
|
|
|
5.9
|
%
|
|
149.2
|
%
|
Professional service fees
|
3.5
|
|
|
12.6
|
|
|
10.9
|
|
|
(72.2
|
)%
|
|
15.6
|
%
|
|||
Acquisition-related adjustments
|
(3.4
|
)
|
|
(0.1
|
)
|
|
0.2
|
|
|
3,300.0
|
%
|
|
(150.0
|
)%
|
|||
Total Acquisition-related costs, net
|
$
|
16.1
|
|
|
$
|
27.7
|
|
|
$
|
17.2
|
|
|
(41.9
|
)%
|
|
61.0
|
%
|
As a percentage of total revenue
|
0.8
|
%
|
|
1.4
|
%
|
|
0.9
|
%
|
|
|
|
|
|
Personnel
|
|
Facilities
|
|
Total Restructuring Expenses
|
|
Other Charges
|
|
Total
|
||||||||||
Fiscal Year 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
11,563
|
|
|
$
|
25
|
|
|
$
|
11,588
|
|
|
$
|
—
|
|
|
$
|
11,588
|
|
Enterprise
|
4,217
|
|
|
2,243
|
|
|
6,460
|
|
|
—
|
|
|
6,460
|
|
|||||
Automotive
|
4,160
|
|
|
20
|
|
|
4,180
|
|
|
—
|
|
|
4,180
|
|
|||||
Imaging
|
5,304
|
|
|
1,168
|
|
|
6,472
|
|
|
—
|
|
|
6,472
|
|
|||||
Other
|
1,473
|
|
|
647
|
|
|
2,120
|
|
|
7,103
|
|
|
9,223
|
|
|||||
Corporate
|
10,107
|
|
|
953
|
|
|
11,060
|
|
|
14,515
|
|
|
25,575
|
|
|||||
Total fiscal year 2018
|
$
|
36,824
|
|
|
$
|
5,056
|
|
|
$
|
41,880
|
|
|
$
|
21,618
|
|
|
$
|
63,498
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
4,283
|
|
|
$
|
870
|
|
|
$
|
5,153
|
|
|
$
|
8,758
|
|
|
$
|
13,911
|
|
Enterprise
|
2,141
|
|
|
3,480
|
|
|
5,621
|
|
|
—
|
|
|
5,621
|
|
|||||
Automotive
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|||||
Imaging
|
744
|
|
|
387
|
|
|
1,131
|
|
|
—
|
|
|
1,131
|
|
|||||
Other
|
2,954
|
|
|
(15
|
)
|
|
2,939
|
|
|
10,773
|
|
|
13,712
|
|
|||||
Corporate
|
1,337
|
|
|
2,013
|
|
|
3,350
|
|
|
21,491
|
|
|
24,841
|
|
|||||
Total fiscal year 2017
|
$
|
13,297
|
|
|
$
|
6,735
|
|
|
$
|
20,032
|
|
|
$
|
41,022
|
|
|
$
|
61,054
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
3,531
|
|
|
$
|
1,398
|
|
|
$
|
4,929
|
|
|
$
|
—
|
|
|
$
|
4,929
|
|
Enterprise
|
1,214
|
|
|
2,782
|
|
|
3,996
|
|
|
—
|
|
|
3,996
|
|
|||||
Automotive
|
1,967
|
|
|
—
|
|
|
1,967
|
|
|
—
|
|
|
1,967
|
|
|||||
Imaging
|
284
|
|
|
478
|
|
|
762
|
|
|
—
|
|
|
762
|
|
|||||
Other
|
3,870
|
|
|
1,557
|
|
|
5,427
|
|
|
(486
|
)
|
|
4,941
|
|
|||||
Corporate
|
2,267
|
|
|
5,391
|
|
|
7,658
|
|
|
971
|
|
|
8,629
|
|
|||||
Total fiscal year 2016
|
$
|
13,133
|
|
|
$
|
11,606
|
|
|
$
|
24,739
|
|
|
$
|
485
|
|
|
$
|
25,224
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Interest income
|
$
|
9.3
|
|
|
$
|
6.9
|
|
|
$
|
4.4
|
|
|
34.7
|
%
|
|
56.0
|
%
|
Interest expense
|
(137.3
|
)
|
|
(156.9
|
)
|
|
(132.7
|
)
|
|
(12.5
|
)%
|
|
18.2
|
%
|
|||
Other expense, net
|
(1.9
|
)
|
|
(21.0
|
)
|
|
(8.5
|
)
|
|
(91.1
|
)%
|
|
147.6
|
%
|
|||
Total other expenses, net
|
$
|
(129.8
|
)
|
|
$
|
(171.0
|
)
|
|
$
|
(136.8
|
)
|
|
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
(Benefit) Provision for income taxes
|
$
|
(56.8
|
)
|
|
$
|
32.0
|
|
|
$
|
14.2
|
|
|
(277.6
|
)%
|
|
125.3
|
%
|
Effective income tax rate
|
26.2
|
%
|
|
(26.9
|
)%
|
|
816.4
|
%
|
|
|
|
|
|
|
|
Fiscal Year 2018
|
|
Fiscal Year 2017
|
|
Fiscal Year 2016
|
|
% Change 2018 vs. 2017
|
|
% Change 2017 vs. 2016
|
||||||||
Segment Revenues
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||
Healthcare
|
$
|
984.8
|
|
|
$
|
899.3
|
|
|
$
|
973.3
|
|
|
9.5
|
%
|
|
(7.6
|
)%
|
Enterprise
|
483.2
|
|
|
474.3
|
|
|
396.0
|
|
|
1.9
|
%
|
|
19.8
|
%
|
|||
Automotive
|
279.4
|
|
|
252.2
|
|
|
214.3
|
|
|
10.8
|
%
|
|
17.7
|
%
|
|||
Imaging
|
212.9
|
|
|
217.7
|
|
|
241.6
|
|
|
(2.2
|
)%
|
|
(9.9
|
)%
|
|||
Other
|
109.1
|
|
|
133.8
|
|
|
154.4
|
|
|
(18.5
|
)%
|
|
(13.4
|
)%
|
|||
Total segment revenues
|
2,069.4
|
|
|
1,977.4
|
|
|
1,979.6
|
|
|
4.7
|
%
|
|
(0.1
|
)%
|
|||
Less: acquisition related revenue adjustments
(a)
|
(17.7
|
)
|
|
(38.0
|
)
|
|
(30.7
|
)
|
|
(53.4
|
)%
|
|
23.9
|
%
|
|||
Total revenues
|
$
|
2,051.7
|
|
|
$
|
1,939.4
|
|
|
$
|
1,948.9
|
|
|
5.8
|
%
|
|
(0.5
|
)%
|
Segment Profit
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Healthcare
|
$
|
331.4
|
|
|
$
|
262.1
|
|
|
$
|
313.5
|
|
|
26.4
|
%
|
|
(16.4
|
)%
|
Enterprise
|
142.4
|
|
|
135.6
|
|
|
129.3
|
|
|
5.0
|
%
|
|
4.9
|
%
|
|||
Automotive
|
109.9
|
|
|
118.9
|
|
|
95.7
|
|
|
(7.6
|
)%
|
|
24.3
|
%
|
|||
Imaging
|
67.4
|
|
|
79.5
|
|
|
100.8
|
|
|
(15.2
|
)%
|
|
(21.1
|
)%
|
|||
Other
|
28.4
|
|
|
41.6
|
|
|
38.4
|
|
|
(31.6
|
)%
|
|
8.2
|
%
|
|||
Total segment profit
|
$
|
679.5
|
|
|
$
|
637.7
|
|
|
$
|
677.6
|
|
|
6.5
|
%
|
|
(5.9
|
)%
|
Segment Profit Margin
|
|
|
|
|
|
|
|
|
|
||||||||
Healthcare
|
33.6
|
%
|
|
29.1
|
%
|
|
32.2
|
%
|
|
4.5
|
|
|
(3.1
|
)
|
|||
Enterprise
|
29.5
|
%
|
|
28.6
|
%
|
|
32.6
|
%
|
|
0.9
|
|
|
(4.0
|
)
|
|||
Automotive
|
39.3
|
%
|
|
47.1
|
%
|
|
44.6
|
%
|
|
(7.8
|
)
|
|
2.5
|
|
|||
Imaging
|
31.7
|
%
|
|
36.5
|
%
|
|
41.7
|
%
|
|
(4.8
|
)
|
|
(5.2
|
)
|
|||
Other
|
26.1
|
%
|
|
31.1
|
%
|
|
24.9
|
%
|
|
(5.0
|
)
|
|
6.2
|
|
|||
Total segment profit margin
|
32.8
|
%
|
|
32.3
|
%
|
|
34.2
|
%
|
|
0.5
|
|
|
(1.9
|
)
|
(a)
|
Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance.
|
•
|
Healthcare segment revenues
increased
by
$85.5 million
during fiscal year 2018 as the segment recovered from the 2017 Malware Incident throughout the year, as well as the continued market penetration and growth of our Dragon Medical cloud-based solutions and higher revenue from EHR implementation and optimization services, offset in part by the continued erosion of our transcription services.
|
•
|
Enterprise segment revenues
increased
by
$8.9 million
during fiscal year 2018 primarily due to higher contact center license and services revenue, offset in part by lower revenue from our inbound and outbound on-demand solutions.
|
•
|
Automotive segment revenues
increased
by
$27.2 million
during fiscal year 2018 primarily due to higher royalties and revenues from our hosting solutions driven by continued growth in our ASR and infotainment platform services.
|
•
|
Imaging segment revenues
decreased
by
$4.8 million
during fiscal year 2018 primarily due to lower revenue from our scanning and print management solutions, offset in part by higher revenue from our core Imaging solutions due to new product launch.
|
•
|
Other segment revenue
decreased
by
$24.7 million
primarily due to the accelerated declines in both SRS and Devices businesses during fiscal year 2018. The decline in SRS was primarily due to the recent market disruptions in India and Brazil. These markets have experienced a dramatic recent disruption as a result of accelerated change in competition and business models for our SRS mobile operator customers, which has reduced demand for our services. The decline in our Devices business was
|
•
|
Healthcare segment revenues decreased by $74.0 million during fiscal year 2017 primarily due to decreases in hosting revenue and product and licensing revenue. Hosting revenue decreased by $58.2 million primarily due to the negative impact of the 2017 Malware Incident throughout the year, and the continued erosion of the transcription services, offset in part by the positive effect of customers' transition to cloud-based offerings. Product and licensing revenue decreased by $17.9 million primarily as a result of lower revenues from our licensed Dragon Medical product sales as we transition from product licensing to subscription and cloud-based offerings. We estimated the revenue impact of the Malware Incident due to the service interruption to be approximately $65 million for fiscal year 2017.
|
•
|
Enterprise segment revenues increased by $78.3 million during fiscal year 2017 primarily due to the incremental revenue from recent acquisitions, increases in our omni-channel cloud offerings, and the continued strength in our on-premise and on-demand service portfolios.
|
•
|
Automotive segment revenues increased by $37.9 million during fiscal year 2017 primarily due to higher royalties and revenues from our hosting solutions driven by continued growth in our speech recognition and infotainment platform services.
|
•
|
Imaging segment revenues decreased by $23.8 million during fiscal year 2017 primarily due to the lower sales from our MFP solutions.
|
•
|
Other segment revenues decreased by $20.7 million during fiscal year 2017 primarily due to declines in both the SRS and Devices business.
|
•
|
Healthcare segment profit
increased
by
$69.2 million
, or
26.4%
, primarily due to higher segment revenue and higher gross margin. Healthcare operating results for fiscal year 2017 was negatively impacted by the 2017 Malware Incident. The gross margin for fiscal year 2018 reflected a favorable shift in revenue mix towards higher margin Dragon Medical cloud-based offerings, offset in part by the increase in EHR implementation and optimization services which carried lower margins. As a result, segment profit margin
increased
by
4.5
percentage points, to
33.6%
for fiscal year 2018.
|
•
|
Enterprise segment profit
increased
by
$6.8 million
, or
5.0%
, primarily due to higher segment revenue, offset in part by lower gross margin. The lower gross margin was primarily due to higher infrastructure costs and increased headcount to support future growth. As a result, segment profit margin
increased
by
0.9
percentage points to
29.5%
for fiscal year 2018 from
28.6%
for fiscal year 2017.
|
•
|
Automotive segment profit
decreased
by
$9.0 million
, or
7.6%
, primarily due to lower gross margin and higher R&D expenses, offset in part by higher revenue. The lower gross margin was primarily driven by increased professional services headcount to support implementation of our connected solutions across existing and new customer base. The higher R&D expense was primarily driven by our increased investment in new technologies. As a result, segment profit margin
decreased
by
7.8
percentage points to
39.3%
for fiscal year 2018 from
47.1%
for fiscal year 2017.
|
•
|
Imaging segment profit
decreased
by
$12.1 million
, or
15.2%
, primarily due to lower segment revenue, lower gross margin, and higher operating expenses. Gross margin declined as a result of an unfavorable shift in revenue mix from higher margin software revenue to lower margin hardware revenue. Operating expenses increased primarily due to higher sales and marketing expenses to support new products and solutions, and drive greater market penetration. As a result, segment profit margin
decreased
by
4.8
percentage points to
31.7%
for fiscal year 2018 from
36.5%
for fiscal year 2017.
|
•
|
Other segment profit decreased by
$13.2 million
, or
31.6%
, primarily due to lower revenue and the margin compression in SRS and Devices. Segment profit margin declined primarily due to lower revenues and relatively fixed costs and expenses
|
•
|
Healthcare segment profit decreased by $51.3 million, or 16.4%, primarily due to lower segment revenue and lower gross margin as a result of the negative impact of the 2017 Malware Incident and the continued erosion of the transcription services, offset in part by the positive effect of customers' transition to cloud based offerings. Segment profit margin decreased by 3.1 percentage points, to 29.1% for fiscal year 2017 from 32.2% for fiscal year 2016, primarily due to lower gross margin.
|
•
|
Enterprise segment profit increased by $6.4 million, or 4.9%, primarily due to higher segment revenue, offset in part by lower gross margin and higher R&D expenses. Gross margin was lower as our recently acquired entities carried lower gross margins. R&D expenses increased as a result of increased R&D headcount due to recent acquisitions. Segment profit margin decreased by 4.0 percentage points to 28.6% for fiscal year 2017 from 32.6% for fiscal year 2016, primarily due to lower gross margin and higher operating expenses margin.
|
•
|
Automotive segment profit increased by $23.2 million, or 24.3%, primarily due to higher revenues and gross margin. The gross margin improvement was primarily due to a favorable shift to higher margin cloud-based and licensing offerings. Segment profit margin increased by 2.5 percentage points to 47.1% for fiscal year 2017 from 44.6% for fiscal year 2016, primarily due to higher gross margin and lower operating expense margin as the segment continued to benefit from our costs savings and process optimization initiatives.
|
•
|
Imaging segment profit decreased by $21.3 million, or 21.1%, primarily due to lower segment revenue. Segment profit margin decreased by 5.2 percentage points to 36.5% during fiscal year 2017 from 41.7% during fiscal year 2016, primarily due to relatively flat operating expenses on lower revenues.
|
•
|
Other segment profit increased by $3.1 million, or 8.2%, primarily due to higher gross margin, offset in part by lower revenue. Higher gross margin was primarily driven by the timing of product and licensing revenue. Segment profit margin increased by 6.2 percentage points to 31.1% during fiscal year 2017 from 24.9% during fiscal year 2016.
|
•
|
An increase of
$25.0 million
driven by favorable changes in working capital, primarily due to the timing of billing and collections; and
|
•
|
An increase in cash inflows of
$39.3 million
from deferred revenue. Deferred revenue contributed cash inflow of
$86.2 million
in fiscal year 2018, as compared to
$46.9 million
in fiscal year 2017, primarily driven by continued growth of our Automotive connected solutions and Healthcare bundled offerings.
|
•
|
A decrease of $77.1 million in cash flows resulting from a higher net loss, exclusive of non-cash adjustment items;
|
•
|
A decrease of $95.0 million in cash flows resulting from unfavorable changes in working capital, excluding deferred revenue; and
|
•
|
A decrease in cash inflows of $14.9 million from deferred revenue. Deferred revenue contributed cash inflow of $46.9 million in fiscal year 2017, as compared to $61.7 million in fiscal year 2016. The deferred revenue growth in fiscal year 2017 was driven primarily by our hosting solutions in automotive connected services within our Mobile segment and bundled offerings within our Healthcare segment.
|
•
|
An increase of
$280.3 million
in net proceeds from the sale and purchase of marketable securities and other investments; and
|
•
|
A decrease of
$13.0 million
in capital expenditures.
|
•
|
An increase in cash outflows of $214.8 million for payments of marketable securities and other investments, offset in part by;
|
•
|
An increase in cash inflows of $91.6 million for proceeds from marketable securities and other investment; and
|
•
|
A decrease in cash outflows of $59.0 million for business and technology acquisitions.
|
•
|
A decrease in cash inflows of
$837.5 million
from debt issuance. During fiscal year 2017, the cash inflows from debt activities includes $495.0 million net proceeds from the issuance of 5.625% Senior Notes due 2026; and $343.6 million net proceeds from the issuance of our 1.25% 2025 Convertible Debentures;
|
•
|
An increase in cash outflows of
$37.0 million
related to share repurchases. During fiscal year 2018 and 2017, we repurchased
9.7 million
shares and
5.8 million
shares for
$136.1 million
and
$99.1 million
, respectively; and
|
•
|
An increase in cash outflows of
$24.8 million
related to acquisition payments with extended payment terms, offset in part by,
|
•
|
A decrease in cash outflows of
$152.9 million
from the redemption and repayment of debt. During fiscal year 2018, holders of approximately $331.2 million in aggregate principal amount of the 2.75% 2031 Debentures exercised their right to require us to repurchase such debentures, and we repurchased
$150.0 million
in aggregate principal amount of our 2020 Senior Notes. During fiscal year 2017, we repurchased $600.0 million in aggregate principal amount of our 2020 Senior Notes and $17.8 million in aggregate principal amount of our 2031 Convertible Debentures.
|
•
|
A decrease in cash outflows of $600.4 million related to share repurchases. We repurchased 5.8 million shares of our common stock for $99.1 million in fiscal year 2017 as compared to 9.4 million shares repurchased under our share repurchase program and 26.3 million shares repurchased from the Icahn Group for total cash outflow of $699.5 million in fiscal year 2016;
|
•
|
A decrease in net cash inflows of $244.1 million from debt activities. The fiscal year 2017 activity included approximately$495.0 million net proceeds from the issuance of our 2026 Senior Notes, approximately $343.6 million net proceeds from the issuance of our 1.25% 2025 Debentures, offset by the repurchases of $600.0 million in aggregate principal of our 2020 Senior Notes and $17.8 million in aggregate principal of our 2031 Convertible Debentures. The fiscal year 2016 activity included proceeds of $663.8 million, net of issuance costs, from the issuance of our 1.0% 2035 Debentures offset by the repurchase of $38.3 million in aggregate principal on our 2.75% Senior Convertible Debentures due in 2031 and repayment of $472.5 million on our term loan under the amended and restated credit agreement; and
|
•
|
An increase in cash outflows of $14.5 million as a result of higher cash payments required to net share settle employee equity awards due to the increase in the intrinsic value of shares vested during fiscal year 2017 as compared to fiscal year 2016.
|
|
|
Payments Due by Fiscal Year Ended September 30,
|
||||||||||||||||||
Contractual Obligations
|
|
Total
|
|
2019
|
|
2020 and 2021
|
|
2022 and 2023
|
|
Thereafter
|
||||||||||
Convertible Debentures
(1)
|
|
$
|
1,337.0
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
987.0
|
|
|
$
|
350.0
|
|
Senior Notes
|
|
1,100.0
|
|
|
—
|
|
|
300.0
|
|
|
—
|
|
|
800.0
|
|
|||||
Interest payable on long-term debt
(2)
|
|
458.7
|
|
|
78.8
|
|
|
141.0
|
|
|
113.8
|
|
|
125.1
|
|
|||||
Letter of Credit
(3)
|
|
6.9
|
|
|
6.8
|
|
|
0.1
|
|
|
—
|
|
|
—
|
|
|||||
Lease obligations and other liabilities:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Operating leases
|
|
165.0
|
|
|
29.1
|
|
|
39.5
|
|
|
32.0
|
|
|
64.4
|
|
|||||
Operating leases under restructuring
(4)
|
|
60.9
|
|
|
10.1
|
|
|
17.9
|
|
|
17.2
|
|
|
15.7
|
|
|||||
Purchase commitments for inventory, property and equipment
(5)
|
|
32.6
|
|
|
8.0
|
|
|
13.8
|
|
|
10.8
|
|
|
—
|
|
|||||
Total contractual cash obligations
|
|
$
|
3,161.1
|
|
|
$
|
132.8
|
|
|
$
|
512.3
|
|
|
$
|
1,160.8
|
|
|
$
|
1,355.2
|
|
(1)
|
Pursuant to the terms of each convertible instrument, holders have the right to redeem the debt on specific dates prior to maturity. The repayment schedule above assumes that payment is due on the next redemption date after
September 30, 2018
.
|
(2)
|
Interest per annum is due and payable semi-annually and is determined based on the outstanding principal as of
September 30, 2018
, the stated interest rate of each debt instrument and the assumed redemption dates discussed above.
|
(3)
|
Letters of Credit are in place primarily to secure future operating lease payments.
|
(4)
|
Obligations include contractual lease commitments related to facilities that were part of restructuring plans. As of
September 30, 2018
, we have subleased certain of the facilities with total sublease income of
$42.8 million
through fiscal year
2027
.
|
(5)
|
These amounts include non-cancelable purchase commitments for property and equipment as well as inventory in the normal course of business to fulfill customer backlog.
|
•
|
estimated fair values of intangible assets;
|
•
|
estimated fair market values of legal performance commitments to customers, assumed from the acquiree under existing contractual obligations (classified as deferred revenue) at the date of acquisition;
|
•
|
estimated fair market values of stock awards assumed from the acquiree that are included in the purchase price;
|
•
|
estimated fair market value of required payments under contingent consideration provisions;
|
•
|
estimated income tax assets and liabilities assumed from the acquiree; and
|
•
|
estimated fair value of pre-acquisition contingencies assumed from the acquiree.
|
•
|
future expected cash flows from software license sales, support agreements, consulting contracts, hosting services, other customer contracts and acquired developed technologies and patents;
|
•
|
expected costs to develop in-process research and development projects into commercially viable products and the estimated cash flows from the projects when completed;
|
•
|
the acquired company’s brand and competitive position, as well as assumptions about the period during which the acquired brand will continue to be used in the combined company’s product portfolio; and
|
•
|
discount rates.
|
|
September 30, 2018
|
||||||
|
Fair value
|
|
Conversion
value
|
|
Increase to
fair value
|
|
Increase to
conversion
value
|
2.75% 2031 Debentures
|
$46.4
|
|
$25.0
|
|
$0.1
|
|
$2.5
|
1.5% 2035 Debentures
|
$267.8
|
|
$196.5
|
|
$9.7
|
|
$19.7
|
1.0% 2035 Debentures
|
$634.1
|
|
$430.4
|
|
$19.9
|
|
$43.0
|
1.25 % 2025 Debentures
|
$361.0
|
|
$272.9
|
|
$19.1
|
|
$27.3
|
Item 8.
|
Financial Statements and Supplementary Data
|
|
Page
|
|
|
|
BDO USA, LLP
|
|
|
|
BDO USA, LLP
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In thousands, except per share amounts)
|
||||||||||
Revenues:
|
|
|
|
|
|
|
|
|
|||
Professional services and hosting
|
$
|
1,049,448
|
|
|
$
|
976,893
|
|
|
$
|
955,329
|
|
Product and licensing
|
684,230
|
|
|
635,391
|
|
|
669,227
|
|
|||
Maintenance and support
|
317,983
|
|
|
327,078
|
|
|
324,347
|
|
|||
Total revenues
|
2,051,661
|
|
|
1,939,362
|
|
|
1,948,903
|
|
|||
Cost of revenues:
|
|
|
|
|
|
|
|
|
|||
Professional services and hosting
|
681,516
|
|
|
660,849
|
|
|
626,168
|
|
|||
Product and licensing
|
77,086
|
|
|
74,004
|
|
|
86,379
|
|
|||
Maintenance and support
|
58,095
|
|
|
54,094
|
|
|
54,077
|
|
|||
Amortization of intangible assets
|
56,873
|
|
|
64,853
|
|
|
62,876
|
|
|||
Total cost of revenues
|
873,570
|
|
|
853,800
|
|
|
829,500
|
|
|||
Gross profit
|
1,178,091
|
|
|
1,085,562
|
|
|
1,119,403
|
|
|||
Operating expenses:
|
|
|
|
|
|
|
|
|
|||
Research and development
|
305,323
|
|
|
266,097
|
|
|
271,130
|
|
|||
Sales and marketing
|
388,305
|
|
|
398,130
|
|
|
390,866
|
|
|||
General and administrative
|
229,774
|
|
|
166,677
|
|
|
168,473
|
|
|||
Amortization of intangible assets
|
91,093
|
|
|
113,895
|
|
|
108,021
|
|
|||
Acquisition-related costs, net
|
16,101
|
|
|
27,740
|
|
|
17,166
|
|
|||
Restructuring and other charges, net
|
63,498
|
|
|
61,054
|
|
|
25,224
|
|
|||
Impairment of goodwill and other intangible assets
|
170,941
|
|
|
—
|
|
|
—
|
|
|||
Total operating expenses
|
1,265,035
|
|
|
1,033,593
|
|
|
980,880
|
|
|||
(Loss) income from operations
|
(86,944
|
)
|
|
51,969
|
|
|
138,523
|
|
|||
Other income (expense):
|
|
|
|
|
|
|
|
|
|||
Interest income
|
9,327
|
|
|
6,922
|
|
|
4,438
|
|
|||
Interest expense
|
(137,253
|
)
|
|
(156,889
|
)
|
|
(132,732
|
)
|
|||
Other expense, net
|
(1,865
|
)
|
|
(21,017
|
)
|
|
(8,490
|
)
|
|||
(Loss) income before income taxes
|
(216,735
|
)
|
|
(119,015
|
)
|
|
1,739
|
|
|||
(Benefit) provision for income taxes
|
(56,807
|
)
|
|
31,981
|
|
|
14,197
|
|
|||
Net loss
|
$
|
(159,928
|
)
|
|
$
|
(150,996
|
)
|
|
$
|
(12,458
|
)
|
Net loss per share:
|
|
|
|
|
|
|
|
|
|||
Basic
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
$
|
(0.04
|
)
|
Diluted
|
$
|
(0.55
|
)
|
|
$
|
(0.52
|
)
|
|
$
|
(0.04
|
)
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|||
Basic
|
291,318
|
|
|
289,348
|
|
|
292,129
|
|
|||
Diluted
|
291,318
|
|
|
289,348
|
|
|
292,129
|
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In thousands)
|
||||||||||
Net loss
|
$
|
(159,928
|
)
|
|
$
|
(150,996
|
)
|
|
$
|
(12,458
|
)
|
Other comprehensive income (loss):
|
|
|
|
|
|
||||||
Foreign currency translation adjustment
|
(23,973
|
)
|
|
13,027
|
|
|
2,421
|
|
|||
Pension adjustments
|
2,644
|
|
|
1,774
|
|
|
(1,741
|
)
|
|||
Unrealized (loss) gain on marketable securities
|
(192
|
)
|
|
(9
|
)
|
|
131
|
|
|||
Total other comprehensive (loss) income, net
|
(21,521
|
)
|
|
14,792
|
|
|
811
|
|
|||
Comprehensive loss
|
$
|
(181,449
|
)
|
|
$
|
(136,204
|
)
|
|
$
|
(11,647
|
)
|
|
September 30, 2018
|
|
September 30, 2017
|
||||
|
(In thousands, except
per share amounts)
|
||||||
ASSETS
|
|||||||
Current assets:
|
|
|
|
|
|
||
Cash and cash equivalents
|
$
|
315,963
|
|
|
$
|
592,299
|
|
Marketable securities
|
135,579
|
|
|
251,981
|
|
||
Accounts receivable, less allowances for doubtful accounts of $11,724 and $14,333
|
378,832
|
|
|
395,392
|
|
||
Prepaid expenses and other current assets
|
98,257
|
|
|
88,269
|
|
||
Total current assets
|
928,631
|
|
|
1,327,941
|
|
||
Marketable securities
|
21,932
|
|
|
29,844
|
|
||
Land, building and equipment, net
|
155,894
|
|
|
176,548
|
|
||
Goodwill
|
3,504,457
|
|
|
3,590,608
|
|
||
Intangible assets, net
|
549,508
|
|
|
664,474
|
|
||
Other assets
|
141,957
|
|
|
142,508
|
|
||
Total assets
|
$
|
5,302,379
|
|
|
$
|
5,931,923
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|||||||
Current liabilities:
|
|
|
|
|
|
||
Current portion of long-term debt
|
$
|
—
|
|
|
$
|
376,121
|
|
Contingent and deferred acquisition payments
|
14,211
|
|
|
28,860
|
|
||
Accounts payable (including $416 due to a related party as of September 30, 2018, as more fully described in Note 19)
|
84,516
|
|
|
94,604
|
|
||
Accrued expenses and other current liabilities
|
281,644
|
|
|
245,901
|
|
||
Deferred revenue
|
383,793
|
|
|
366,042
|
|
||
Total current liabilities
|
764,164
|
|
|
1,111,528
|
|
||
Long-term debt
|
2,185,361
|
|
|
2,241,283
|
|
||
Deferred revenue, net of current portion
|
489,177
|
|
|
423,929
|
|
||
Deferred tax liabilities
|
49,931
|
|
|
131,320
|
|
||
Other liabilities
|
96,250
|
|
|
92,481
|
|
||
Total liabilities
|
3,584,883
|
|
|
4,000,541
|
|
||
Commitments and contingencies (Note 16)
|
|
|
|
|
|
||
Stockholders’ equity:
|
|
|
|
|
|
||
Common stock, $0.001 par value per share; 560,000 shares authorized; 291,504 and 293,938 shares issued and 287,753 and 290,187 shares outstanding, respectively
|
291
|
|
|
294
|
|
||
Additional paid-in capital
|
2,597,693
|
|
|
2,629,245
|
|
||
Treasury stock, at cost (3,751 shares)
|
(16,788
|
)
|
|
(16,788
|
)
|
||
Accumulated other comprehensive loss
|
(122,863
|
)
|
|
(101,342
|
)
|
||
Accumulated deficit
|
(740,837
|
)
|
|
(580,027
|
)
|
||
Total stockholders’ equity
|
1,717,496
|
|
|
1,931,382
|
|
||
Total liabilities and stockholders’ equity
|
$
|
5,302,379
|
|
|
$
|
5,931,923
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated
|
|
|
|
|
||||||||||||||
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Treasury Stock
|
|
Other Comprehensive Loss
|
|
Accumulated Deficit
|
|
Total Stockholders' Equity
|
||||||||||||||||||
|
Shares
|
|
Amount
|
|
|
Shares
|
|
Amount
|
|
|
|
||||||||||||||||||
|
(In thousands)
|
||||||||||||||||||||||||||||
Balance at September 30, 2015
|
313,531
|
|
|
$
|
314
|
|
|
$
|
2,815,244
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(116,945
|
)
|
|
$
|
(416,573
|
)
|
|
$
|
2,265,252
|
|
Issuance of common stock under employee stock plans
|
11,131
|
|
|
11
|
|
|
16,839
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,850
|
|
||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(3,619
|
)
|
|
(4
|
)
|
|
(68,666
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(68,670
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
162,884
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
162,884
|
|
||||||
Repurchase and retirement of common stock
|
(35,753
|
)
|
|
(36
|
)
|
|
(698,658
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(698,694
|
)
|
||||||
Net issuance of common stock in connection with acquisitions and collaboration agreements
|
6,094
|
|
|
6
|
|
|
89,785
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
89,791
|
|
||||||
Equity portion of convertible debt issuance/retirement, net of tax effect
|
—
|
|
|
—
|
|
|
175,564
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
175,564
|
|
||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(12,458
|
)
|
|
(12,458
|
)
|
||||||
Other comprehensive loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
811
|
|
|
—
|
|
|
811
|
|
||||||
Balance at September 30, 2016
|
291,384
|
|
|
291
|
|
|
2,492,992
|
|
|
3,751
|
|
|
(16,788
|
)
|
|
(116,134
|
)
|
|
(429,031
|
)
|
|
1,931,330
|
|
||||||
Issuance of common stock under employee stock plans
|
10,709
|
|
|
11
|
|
|
17,372
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
17,383
|
|
||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(3,377
|
)
|
|
(3
|
)
|
|
(55,129
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(55,132
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
160,575
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
160,575
|
|
||||||
Repurchase and retirement of common stock
|
(5,797
|
)
|
|
(6
|
)
|
|
(99,071
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(99,077
|
)
|
||||||
Net issuance of common stock in connection with acquisitions and charitable contributions
|
1,019
|
|
|
1
|
|
|
16,346
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
16,347
|
|
||||||
Equity portion of convertible debt issuance/retirement, net of tax effect
|
—
|
|
|
—
|
|
|
96,160
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
96,160
|
|
||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(150,996
|
)
|
|
(150,996
|
)
|
||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
14,792
|
|
|
—
|
|
|
14,792
|
|
||||||
Balance at September 30, 2017
|
293,938
|
|
|
294
|
|
|
2,629,245
|
|
|
3,751
|
|
|
(16,788
|
)
|
|
(101,342
|
)
|
|
(580,027
|
)
|
|
1,931,382
|
|
||||||
Prior period adjustment related to early adoption of ASU 2016-16
|
—
|
|
|
—
|
|
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(882
|
)
|
|
(882
|
)
|
|||||||
Issuance of common stock under employee stock plans
|
10,568
|
|
|
10
|
|
|
18,374
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
18,384
|
|
||||||
Cancellation of restricted stock, and repurchase of common stock at cost for employee tax withholding
|
(3,304
|
)
|
|
(3
|
)
|
|
(52,333
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(52,336
|
)
|
||||||
Stock-based compensation
|
—
|
|
|
—
|
|
|
138,487
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
138,487
|
|
||||||
Repurchase and retirement of common stock
|
(9,698
|
)
|
|
(10
|
)
|
|
(136,080
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(136,090
|
)
|
||||||
Net loss
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(159,928
|
)
|
|
(159,928
|
)
|
||||||
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(21,521
|
)
|
|
—
|
|
|
(21,521
|
)
|
||||||
Balance at September 30, 2018
|
291,504
|
|
|
$
|
291
|
|
|
$
|
2,597,693
|
|
|
3,751
|
|
|
$
|
(16,788
|
)
|
|
$
|
(122,863
|
)
|
|
$
|
(740,837
|
)
|
|
$
|
1,717,496
|
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
|
(In thousands)
|
||||||||||
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|||
Net loss
|
$
|
(159,928
|
)
|
|
$
|
(150,996
|
)
|
|
$
|
(12,458
|
)
|
Adjustments to reconcile net loss to net cash provided by operating activities:
|
|
|
|
|
|
|
|
|
|||
Depreciation and amortization
|
210,316
|
|
|
234,413
|
|
|
231,474
|
|
|||
Stock-based compensation
|
150,785
|
|
|
154,272
|
|
|
163,828
|
|
|||
Non-cash interest expense
|
49,091
|
|
|
59,295
|
|
|
47,105
|
|
|||
Deferred tax (benefit) provision
|
(87,217
|
)
|
|
4,855
|
|
|
(12,014
|
)
|
|||
(Gain) loss on extinguishment of debt
|
(348
|
)
|
|
18,565
|
|
|
4,851
|
|
|||
Impairment of goodwill and other intangible assets
|
170,941
|
|
|
—
|
|
|
—
|
|
|||
Impairment of fixed assets
|
10,550
|
|
|
16,351
|
|
|
2,480
|
|
|||
Other
|
2,230
|
|
|
8,403
|
|
|
(3,055
|
)
|
|||
Changes in operating assets and liabilities, excluding effects of acquisitions:
|
|
|
|
|
|
|
|
|
|||
Accounts receivable
|
19,641
|
|
|
(6,349
|
)
|
|
25,450
|
|
|||
Prepaid expenses and other assets
|
(20,389
|
)
|
|
(14,661
|
)
|
|
(9,645
|
)
|
|||
Accounts payable
|
(14,315
|
)
|
|
(1,207
|
)
|
|
38,206
|
|
|||
Accrued expenses and other liabilities
|
26,847
|
|
|
9,040
|
|
|
27,826
|
|
|||
Deferred revenue
|
86,222
|
|
|
46,886
|
|
|
61,747
|
|
|||
Net cash provided by operating activities
|
444,426
|
|
|
378,867
|
|
|
565,795
|
|
|||
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|||
Capital expenditures
|
(48,845
|
)
|
|
(61,835
|
)
|
|
(54,883
|
)
|
|||
Payments for business and technology acquisitions, net of cash acquired (including cash payments of $5,725 to a related party for fiscal 2018, see Note 19)
|
(110,170
|
)
|
|
(113,769
|
)
|
|
(172,763
|
)
|
|||
Purchases of marketable securities and other investments
|
(201,995
|
)
|
|
(332,470
|
)
|
|
(117,640
|
)
|
|||
Proceeds from sales and maturities of marketable securities and other investments
|
323,695
|
|
|
173,864
|
|
|
82,285
|
|
|||
Net cash used in investing activities
|
(37,315
|
)
|
|
(334,210
|
)
|
|
(263,001
|
)
|
|||
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|||
Repayment and redemption of debt
|
(481,172
|
)
|
|
(634,055
|
)
|
|
(511,844
|
)
|
|||
Proceeds from issuance of long-term debt, net of issuance costs
|
—
|
|
|
837,482
|
|
|
959,358
|
|
|||
Payments for repurchase of common stock
|
(136,090
|
)
|
|
(99,077
|
)
|
|
(699,472
|
)
|
|||
Acquisition payments with extended payment terms
|
(24,842
|
)
|
|
—
|
|
|
—
|
|
|||
Proceeds from issuance of common stock from employee stock plans
|
18,384
|
|
|
17,383
|
|
|
16,850
|
|
|||
Payments for taxes related to net share settlement of equity awards
|
(55,396
|
)
|
|
(54,099
|
)
|
|
(68,636
|
)
|
|||
Other financing activities
|
(1,232
|
)
|
|
(583
|
)
|
|
(1,371
|
)
|
|||
Net cash (used in) provided by financing activities
|
(680,348
|
)
|
|
67,051
|
|
|
(305,115
|
)
|
|||
Effects of exchange rate changes on cash and cash equivalents
|
(3,099
|
)
|
|
(1,029
|
)
|
|
4,492
|
|
|||
Net (decrease) increase in cash and cash equivalents
|
(276,336
|
)
|
|
110,679
|
|
|
2,171
|
|
|||
Cash and cash equivalents at beginning of year
|
592,299
|
|
|
481,620
|
|
|
479,449
|
|
|||
Cash and cash equivalents at end of year
|
$
|
315,963
|
|
|
$
|
592,299
|
|
|
$
|
481,620
|
|
1.
|
Organization and Presentation
|
•
|
estimated fair values of intangible assets;
|
•
|
estimated fair values of legal performance commitments to customers, assumed from the acquiree under existing contractual obligations (classified as deferred revenue);
|
•
|
estimated fair values of stock awards assumed from the acquiree that are included in the purchase price;
|
•
|
estimated fair value of required payments under contingent consideration provisions;
|
•
|
estimated income tax assets and liabilities assumed from the acquiree; and
|
•
|
estimated fair value of pre-acquisition contingencies assumed from the acquiree.
|
|
Allowance for Doubtful Accounts
|
|
Allowance
for Sales
Returns
|
||||
Balance at September 30, 2015
|
$
|
9,184
|
|
|
$
|
8,172
|
|
Bad debt provision
|
3,103
|
|
|
—
|
|
||
Write-offs, net of recoveries
|
(1,249
|
)
|
|
—
|
|
||
Revenue adjustments, net
|
—
|
|
|
(616
|
)
|
||
Balance at September 30, 2016
|
11,038
|
|
|
7,556
|
|
||
Bad debt provisions
|
3,792
|
|
|
—
|
|
||
Write-offs, net of recoveries
|
(497
|
)
|
|
—
|
|
||
Revenue adjustments, net
(a)
|
—
|
|
|
27,750
|
|
||
Balance at September 30, 2017
|
14,333
|
|
|
35,306
|
|
||
Bad debt provisions
|
2,666
|
|
|
—
|
|
||
Write-offs, net of recoveries
|
(5,275
|
)
|
|
—
|
|
||
Revenue adjustments, net
(b)
|
—
|
|
|
(23,982
|
)
|
||
Balance at September 30, 2018
|
$
|
11,724
|
|
|
$
|
11,324
|
|
|
September 30,
2018 |
|
September 30,
2017 |
||||
Components and parts
|
$
|
6,948
|
|
|
$
|
5,684
|
|
Finished products
|
610
|
|
|
404
|
|
||
Total Inventories
|
$
|
7,558
|
|
|
$
|
6,088
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
Transition and integration costs
|
$
|
16,067
|
|
|
$
|
15,224
|
|
|
$
|
6,070
|
|
Professional service fees
|
3,450
|
|
|
12,622
|
|
|
10,876
|
|
|||
Acquisition-related adjustments
|
(3,416
|
)
|
|
(106
|
)
|
|
220
|
|
|||
Total
|
$
|
16,101
|
|
|
$
|
27,740
|
|
|
$
|
17,166
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
Foreign currency translation adjustment
|
$
|
(118,220
|
)
|
|
$
|
(94,247
|
)
|
|
$
|
(107,274
|
)
|
Unrealized (losses) gains on marketable securities
|
(115
|
)
|
|
77
|
|
|
86
|
|
|||
Net unrealized losses on post-retirement benefits
|
(4,528
|
)
|
|
(7,172
|
)
|
|
(8,946
|
)
|
|||
Accumulated other comprehensive loss
|
$
|
(122,863
|
)
|
|
$
|
(101,342
|
)
|
|
$
|
(116,134
|
)
|
|
TouchCommerce
|
||
Purchase consideration:
|
|
||
Cash
|
$
|
113,008
|
|
Common stock
(a)
|
85,000
|
|
|
Deferred acquisition payment
|
19,458
|
|
|
Total purchase consideration
|
$
|
217,466
|
|
|
|
||
Allocation of the purchase consideration:
|
|
||
Cash
|
$
|
137
|
|
Accounts receivable
(b)
|
14,897
|
|
|
Goodwill
|
117,576
|
|
|
Identifiable intangible assets
(c)
|
110,800
|
|
|
Other assets
|
1,521
|
|
|
Total assets acquired
|
244,931
|
|
|
Current liabilities
|
(4,134
|
)
|
|
Deferred tax liability
|
(19,913
|
)
|
|
Deferred revenue
|
(2,784
|
)
|
|
Other long-term liabilities
|
(634
|
)
|
|
Total liabilities assumed
|
(27,465
|
)
|
|
Net assets acquired
|
$
|
217,466
|
|
(c)
|
The following are the identifiable intangible assets acquired and their respective weighted average useful lives, as determined based on preliminary valuations (dollars in thousands):
|
|
TouchCommerce
|
||||
|
Amount
|
|
Weighted
Average
Life
(Years)
|
||
Core and completed technology
|
$
|
26,000
|
|
|
6.0
|
Customer relationships
|
81,600
|
|
|
10.0
|
|
Trade names
|
3,200
|
|
|
5.0
|
|
Total
|
$
|
110,800
|
|
|
|
|
Healthcare
|
|
Enterprise
|
|
Imaging
|
|
Mobile
|
|
Automotive
|
|
Other
|
|
Total
|
||||||||||||||
Balance as of September 30, 2016
|
$
|
1,381,076
|
|
|
$
|
653,368
|
|
|
$
|
257,038
|
|
|
$
|
1,217,397
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
3,508,879
|
|
Acquisitions
|
32,985
|
|
|
14,415
|
|
|
—
|
|
|
13,660
|
|
|
—
|
|
|
—
|
|
|
61,060
|
|
|||||||
Purchase accounting adjustments
|
(49
|
)
|
|
(463
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(512
|
)
|
|||||||
Effect of foreign currency translation
|
4,322
|
|
|
6,152
|
|
|
754
|
|
|
9,953
|
|
|
—
|
|
|
—
|
|
|
21,181
|
|
|||||||
Balance as of September 30, 2017
|
1,418,334
|
|
|
673,472
|
|
|
257,792
|
|
|
1,241,010
|
|
|
—
|
|
|
—
|
|
|
3,590,608
|
|
|||||||
Acquisitions
|
14,936
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
50,193
|
|
|
—
|
|
|
65,129
|
|
|||||||
Purchase accounting adjustments
|
(705
|
)
|
|
—
|
|
|
—
|
|
|
2,697
|
|
|
(3,275
|
)
|
|
—
|
|
|
(1,283
|
)
|
|||||||
Effect of foreign currency translation
|
(2,240
|
)
|
|
(2,116
|
)
|
|
(440
|
)
|
|
5,344
|
|
|
(7,424
|
)
|
|
(1,340
|
)
|
|
(8,216
|
)
|
|||||||
Reorganization (Note 19)
|
—
|
|
|
11,991
|
|
|
—
|
|
|
(1,249,051
|
)
|
|
1,080,453
|
|
|
156,607
|
|
|
—
|
|
|||||||
Impairment charge
(a)
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(141,781
|
)
|
|
(141,781
|
)
|
|||||||
Balance as of September 30, 2018
|
$
|
1,430,325
|
|
|
$
|
683,347
|
|
|
$
|
257,352
|
|
|
$
|
—
|
|
|
$
|
1,119,947
|
|
|
$
|
13,486
|
|
|
$
|
3,504,457
|
|
(a)
|
Represents accumulated impairment charge as of
September 30, 2018
.
|
|
September 30, 2018
|
||||||||||||
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
(a)
|
|
Weighted Average Remaining Life (Years)
|
||||||
Customer relationships
|
$
|
765,571
|
|
|
$
|
(372,121
|
)
|
|
$
|
393,450
|
|
|
6.3
|
Technology and patents
|
327,695
|
|
|
(189,344
|
)
|
|
138,351
|
|
|
3.8
|
|||
Trade names, trademarks, and other
|
57,809
|
|
|
(40,102
|
)
|
|
17,707
|
|
|
2.2
|
|||
Total
|
$
|
1,151,075
|
|
|
$
|
(601,567
|
)
|
|
$
|
549,508
|
|
|
|
(a)
|
As more fully described below, the balance as of
September 30, 2018
reflected impairment charges of
$29.2 million
related to Mobile Operator Services and Devices intangible assets that we recorded during the fourth quarter of fiscal year 2018.
|
|
September 30, 2017
|
||||||||||||
|
Gross Carrying Amount
|
|
Accumulated Amortization
|
|
Net Carrying Amount
|
|
Weighted Average Remaining Life (Years)
|
||||||
Customer relationships
|
$
|
790,846
|
|
|
$
|
(338,511
|
)
|
|
$
|
452,335
|
|
|
7.2
|
Technology and patents
|
447,119
|
|
|
(264,562
|
)
|
|
182,557
|
|
|
4.6
|
|||
Trade names, trademarks, and other
|
58,923
|
|
|
(29,341
|
)
|
|
29,582
|
|
|
2.9
|
|||
Total
|
$
|
1,296,888
|
|
|
$
|
(632,414
|
)
|
|
$
|
664,474
|
|
|
6.3
|
Year Ending September 30,
|
|
Cost of Revenue
|
|
Other Operating Expenses
|
|
Total
|
||||||
2019
|
|
$
|
41,444
|
|
|
$
|
82,384
|
|
|
$
|
123,828
|
|
2020
|
|
36,303
|
|
|
74,500
|
|
|
110,803
|
|
|||
2021
|
|
27,960
|
|
|
68,156
|
|
|
96,116
|
|
|||
2022
|
|
19,466
|
|
|
61,854
|
|
|
81,320
|
|
|||
2023
|
|
10,131
|
|
|
48,701
|
|
|
58,832
|
|
|||
Thereafter
|
|
3,047
|
|
|
75,562
|
|
|
78,609
|
|
|||
Total
|
|
$
|
138,351
|
|
|
$
|
411,157
|
|
|
$
|
549,508
|
|
|
September 30, 2018
|
|
September 30, 2017
|
||||
Trade accounts receivable
|
$
|
368,467
|
|
|
$
|
417,516
|
|
Unbilled accounts receivable under long-term contracts
|
33,413
|
|
|
27,515
|
|
||
Gross accounts receivable
|
401,880
|
|
|
445,031
|
|
||
Less: allowance for doubtful accounts
|
(11,724
|
)
|
|
(14,333
|
)
|
||
Less: allowance for sales returns
|
(11,324
|
)
|
|
(35,306
|
)
|
||
Accounts receivable, net
|
$
|
378,832
|
|
|
$
|
395,392
|
|
|
Useful Life (In Years)
|
|
September 30, 2018
|
|
September 30, 2017
|
|||||
Land
|
—
|
|
|
$
|
2,400
|
|
|
$
|
2,400
|
|
Building
|
30
|
|
|
5,409
|
|
|
5,456
|
|
||
Machinery and equipment
|
3-5
|
|
|
164,089
|
|
|
144,130
|
|
||
Computers, software and equipment
|
3-5
|
|
|
183,904
|
|
|
187,732
|
|
||
Leasehold improvements
|
2-15
|
|
|
37,393
|
|
|
34,478
|
|
||
Furniture and fixtures
|
5-7
|
|
|
18,322
|
|
|
19,171
|
|
||
Construction in progress
|
—
|
|
|
2,088
|
|
|
9,121
|
|
||
Subtotal
|
|
|
|
413,605
|
|
|
402,488
|
|
||
Less: accumulated depreciation
|
|
|
|
(257,711
|
)
|
|
(225,940
|
)
|
||
Land, building and equipment, net
|
|
|
|
$
|
155,894
|
|
|
$
|
176,548
|
|
|
September 30, 2018
|
|
September 30, 2017
|
||||
Compensation
|
$
|
181,992
|
|
|
$
|
159,951
|
|
Accrued interest payable
|
21,326
|
|
|
26,285
|
|
||
Cost of revenue related liabilities
|
32,667
|
|
|
20,124
|
|
||
Consulting and professional fees
|
21,441
|
|
|
12,649
|
|
||
Facilities related liabilities
|
5,340
|
|
|
7,158
|
|
||
Sales and marketing incentives
|
2,904
|
|
|
3,655
|
|
||
Sales and other taxes payable
|
6,602
|
|
|
3,125
|
|
||
Other
|
9,372
|
|
|
12,954
|
|
||
Total
|
$
|
281,644
|
|
|
$
|
245,901
|
|
|
September 30,
2018 |
|
September 30,
2017 |
||||
Current Liabilities:
|
|
|
|
|
|
||
Deferred maintenance revenue
|
$
|
160,146
|
|
|
$
|
162,958
|
|
Unearned revenue
|
223,647
|
|
|
203,084
|
|
||
Total current deferred revenue
|
$
|
383,793
|
|
|
$
|
366,042
|
|
Long-term Liabilities:
|
|
|
|
|
|
||
Deferred maintenance revenue
|
$
|
59,800
|
|
|
$
|
60,298
|
|
Unearned revenue
|
429,377
|
|
|
363,631
|
|
||
Total long-term deferred revenue
|
$
|
489,177
|
|
|
$
|
423,929
|
|
|
September 30, 2018
|
|
September 30, 2017
|
||||
5.625% Senior Notes due 2026, net of deferred issuance costs of $5.1 million and $5.7 million, respectively. Effective interest rate 5.625%.
|
$
|
494,915
|
|
|
$
|
494,298
|
|
5.375% Senior Notes due 2020, net of deferred issuance costs of $1.2 million and $2.3 million, respectively, and unamortized premium of $- and $1.0 million, respectively. Effective interest rate 5.375%.
|
298,759
|
|
|
448,630
|
|
||
6.000% Senior Notes due 2024, net of deferred issuance costs of $1.8 million and $2.1 million, respectively. Effective interest rate 6.000%.
|
298,220
|
|
|
297,910
|
|
||
1.00% Convertible Debentures due 2035, net of unamortized discount of $116.9 million and $140.9 million, respectively, and deferred issuance costs of $5.6 million and $6.9 million, respectively. Effective interest rate 5.622%.
|
553,973
|
|
|
528,690
|
|
||
2.75% Convertible Debentures due 2031, net of unamortized discount of $1.5 million and deferred issuance costs of $0.1 million as of September 30, 2017. Effective interest rate 7.432%.
|
46,568
|
|
|
376,121
|
|
||
1.25% Convertible Debentures due 2025, net of unamortized discount of $82.4 million and $92.7 million, respectively, and deferred issuance costs of $3.7 million and $4.3 million, respectively. Effective interest rate 5.578%.
|
263,863
|
|
|
253,054
|
|
||
1.50% Convertible Debentures due 2035, net of unamortized discount of $32.8 million and $42.5 million, respectively, and deferred issuance costs of $1.1 million and $1.5 million, respectively. Effective interest rate 5.394%.
|
229,906
|
|
|
219,875
|
|
||
Deferred issuance costs related to our Revolving Credit Facility
|
(843
|
)
|
|
(1,174
|
)
|
||
Total debt
|
2,185,361
|
|
|
2,617,404
|
|
||
Less: current portion
|
—
|
|
|
376,121
|
|
||
Total long-term debt
|
$
|
2,185,361
|
|
|
$
|
2,241,283
|
|
Fiscal Year
|
|
Convertible Debentures
(1)
|
|
Senior Notes
|
|
Total
|
||||||
2019
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
2020
|
|
—
|
|
|
300,000
|
|
|
300,000
|
|
|||
2021
|
|
—
|
|
|
—
|
|
|
—
|
|
|||
2022
|
|
310,463
|
|
|
—
|
|
|
310,463
|
|
|||
2023
|
|
676,488
|
|
|
—
|
|
|
676,488
|
|
|||
Thereafter
|
|
350,000
|
|
|
800,000
|
|
|
1,150,000
|
|
|||
Total before unamortized discount
|
|
1,336,951
|
|
|
1,100,000
|
|
|
2,436,951
|
|
|||
Less: unamortized discount and issuance costs
|
|
(242,641
|
)
|
|
(8,949
|
)
|
|
(251,590
|
)
|
|||
Total long-term debt
|
|
$
|
1,094,310
|
|
|
$
|
1,091,051
|
|
|
$
|
2,185,361
|
|
(1)
|
Pursuant to the terms of each convertible instrument, holders have the right to redeem the debt on specific dates prior to maturity. The repayment schedule above assumes that payment is due on the next redemption date after
September 30, 2018
.
|
|
|
|
|
|
||||||
Derivatives Not Designated as Hedges:
|
|
Balance Sheet Classification
|
|
September 30, 2018
|
|
September 30, 2017
|
||||
Foreign currency contracts
|
|
Prepaid expenses and other current assets
|
|
$
|
143
|
|
|
$
|
220
|
|
Foreign currency contracts
|
|
Accrued expenses and other liabilities
|
|
(1,192
|
)
|
|
(373
|
)
|
|
|
Income Statement Classification Income (loss) recognized
|
|
|
||||||||||
Derivatives Not Designated as Hedges:
|
|
|
2018
|
|
2017
|
|
2016
|
|||||||
Foreign currency contracts
|
|
Other expense, net
|
|
$
|
(3,616
|
)
|
|
$
|
6,811
|
|
|
$
|
2,021
|
|
•
|
Level 1:
Quoted prices for identical assets or liabilities in active markets.
|
•
|
Level 2:
Observable inputs other than those described as Level 1.
|
•
|
Level 3:
Unobservable inputs that are supportable by little or no market activities and are based on significant assumptions and estimates.
|
|
September 30, 2018
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds
(a)
|
$
|
200,004
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
200,004
|
|
Time deposits
(b)
|
—
|
|
|
88,158
|
|
|
—
|
|
|
88,158
|
|
||||
Commercial paper, $27,194 at cost
(b)
|
—
|
|
|
27,363
|
|
|
—
|
|
|
27,363
|
|
||||
Corporate notes and bonds, $57,563 at cost
(b)
|
—
|
|
|
57,417
|
|
|
—
|
|
|
57,417
|
|
||||
Foreign currency exchange contracts
(b)
|
—
|
|
|
143
|
|
|
—
|
|
|
143
|
|
||||
Total assets at fair value
|
$
|
200,004
|
|
|
$
|
173,081
|
|
|
$
|
—
|
|
|
$
|
373,085
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Foreign currency exchange contracts
(b)
|
$
|
—
|
|
|
$
|
(1,192
|
)
|
|
$
|
—
|
|
|
$
|
(1,192
|
)
|
Contingent acquisition payments
(c)
|
—
|
|
|
—
|
|
|
(4,000
|
)
|
|
(4,000
|
)
|
||||
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
(1,192
|
)
|
|
$
|
(4,000
|
)
|
|
$
|
(5,192
|
)
|
|
September 30, 2017
|
||||||||||||||
|
Level 1
|
|
Level 2
|
|
Level 3
|
|
Total
|
||||||||
Assets:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Money market funds
(a)
|
$
|
381,899
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
381,899
|
|
Time deposits
(b)
|
—
|
|
|
85,570
|
|
|
—
|
|
|
85,570
|
|
||||
Commercial paper, $41,805 at cost
(b)
|
—
|
|
|
41,968
|
|
|
—
|
|
|
41,968
|
|
||||
Corporate notes and bonds, $74,150 at cost
(b)
|
—
|
|
|
74,067
|
|
|
—
|
|
|
74,067
|
|
||||
Foreign currency exchange contracts
(b)
|
—
|
|
|
220
|
|
|
—
|
|
|
220
|
|
||||
Total assets at fair value
|
$
|
381,899
|
|
|
$
|
201,825
|
|
|
$
|
—
|
|
|
$
|
583,724
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
||||
Foreign currency exchange contracts
(b)
|
$
|
—
|
|
|
$
|
(373
|
)
|
|
$
|
—
|
|
|
$
|
(373
|
)
|
Contingent acquisition payments
(c)
|
—
|
|
|
—
|
|
|
(8,648
|
)
|
|
(8,648
|
)
|
||||
Total liabilities at fair value
|
$
|
—
|
|
|
$
|
(373
|
)
|
|
$
|
(8,648
|
)
|
|
$
|
(9,021
|
)
|
(a)
|
Money market funds and time deposits with original maturity of 90 days or less are included within cash and cash equivalents in the consolidated balance sheets and are valued at quoted market prices in active markets.
|
|
Amount
|
||
Balance as of September 30, 2016
|
$
|
8,240
|
|
Earn-out liability established at time of acquisition
|
8,253
|
|
|
Payments and foreign currency translation
|
(7,830
|
)
|
|
Adjustments to fair value included in acquisition-related costs, net
|
(15
|
)
|
|
Balance as of September 30, 2017
|
8,648
|
|
|
Earn-out liability established at time of acquisition
|
2,000
|
|
|
Payments and foreign currency translation
|
(8,188
|
)
|
|
Adjustments to fair value included in acquisition-related costs, net
|
1,540
|
|
|
Balance as of September 30, 2018
|
$
|
4,000
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
Severance costs
|
$
|
36,824
|
|
|
$
|
13,297
|
|
|
$
|
13,133
|
|
Costs of consolidating duplicate facilities
|
5,056
|
|
|
6,735
|
|
|
11,606
|
|
|||
Total restructuring charges
|
41,880
|
|
|
20,032
|
|
|
24,739
|
|
|||
Other charges
|
21,618
|
|
|
41,022
|
|
|
485
|
|
|||
Total restructuring and other charges, net
|
$
|
63,498
|
|
|
$
|
61,054
|
|
|
$
|
25,224
|
|
|
Personnel
|
|
Facilities
|
|
Total
|
||||||
Balance at September 30, 2015
|
$
|
635
|
|
|
$
|
6,222
|
|
|
$
|
6,857
|
|
Restructuring charges, net
|
13,133
|
|
|
11,606
|
|
|
24,739
|
|
|||
Non-cash adjustment
|
(57
|
)
|
|
164
|
|
|
107
|
|
|||
Cash payments
|
(11,050
|
)
|
|
(6,860
|
)
|
|
(17,910
|
)
|
|||
Balance at September 30, 2016
|
2,661
|
|
|
11,132
|
|
|
13,793
|
|
|||
Restructuring charges, net
|
13,297
|
|
|
6,735
|
|
|
20,032
|
|
|||
Non-cash adjustment
|
—
|
|
|
(1,374
|
)
|
|
(1,374
|
)
|
|||
Cash payments
|
(14,412
|
)
|
|
(7,334
|
)
|
|
(21,746
|
)
|
|||
Balance at September 30, 2017
|
1,546
|
|
|
9,159
|
|
|
10,705
|
|
|||
Restructuring charges, net
|
36,824
|
|
|
5,056
|
|
|
41,880
|
|
|||
Non-cash adjustment
|
—
|
|
|
(998
|
)
|
|
(998
|
)
|
|||
Cash payments
|
(27,778
|
)
|
|
(5,599
|
)
|
|
(33,377
|
)
|
|||
Balance at September 30, 2018
|
$
|
10,592
|
|
|
$
|
7,618
|
|
|
$
|
18,210
|
|
|
Personnel
|
|
Facilities
|
|
Total Restructuring
|
|
Other Charges
|
|
Total
|
||||||||||
Fiscal Year 2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
11,563
|
|
|
$
|
25
|
|
|
$
|
11,588
|
|
|
$
|
—
|
|
|
$
|
11,588
|
|
Enterprise
|
4,217
|
|
|
2,243
|
|
|
6,460
|
|
|
—
|
|
|
6,460
|
|
|||||
Automotive
|
4,160
|
|
|
20
|
|
|
4,180
|
|
|
—
|
|
|
4,180
|
|
|||||
Imaging
|
5,304
|
|
|
1,168
|
|
|
6,472
|
|
|
—
|
|
|
6,472
|
|
|||||
Other
|
1,473
|
|
|
647
|
|
|
2,120
|
|
|
7,103
|
|
|
9,223
|
|
|||||
Corporate
|
10,107
|
|
|
953
|
|
|
11,060
|
|
|
14,515
|
|
|
25,575
|
|
|||||
Total fiscal year 2018
|
$
|
36,824
|
|
|
$
|
5,056
|
|
|
$
|
41,880
|
|
|
$
|
21,618
|
|
|
$
|
63,498
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
4,283
|
|
|
$
|
870
|
|
|
$
|
5,153
|
|
|
$
|
8,758
|
|
|
$
|
13,911
|
|
Enterprise
|
2,141
|
|
|
3,480
|
|
|
5,621
|
|
|
—
|
|
|
5,621
|
|
|||||
Automotive
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|
—
|
|
|
1,838
|
|
|||||
Imaging
|
744
|
|
|
387
|
|
|
1,131
|
|
|
—
|
|
|
1,131
|
|
|||||
Other
|
2,954
|
|
|
(15
|
)
|
|
2,939
|
|
|
10,773
|
|
|
13,712
|
|
|||||
Corporate
|
1,337
|
|
|
2,013
|
|
|
3,350
|
|
|
21,491
|
|
|
24,841
|
|
|||||
Total fiscal year 2017
|
$
|
13,297
|
|
|
$
|
6,735
|
|
|
$
|
20,032
|
|
|
$
|
41,022
|
|
|
$
|
61,054
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Fiscal Year 2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||
Healthcare
|
$
|
3,531
|
|
|
$
|
1,398
|
|
|
$
|
4,929
|
|
|
$
|
—
|
|
|
$
|
4,929
|
|
Enterprise
|
1,214
|
|
|
2,782
|
|
|
3,996
|
|
|
—
|
|
|
3,996
|
|
|||||
Automotive
|
1,967
|
|
|
—
|
|
|
1,967
|
|
|
—
|
|
|
1,967
|
|
|||||
Imaging
|
284
|
|
|
478
|
|
|
762
|
|
|
—
|
|
|
762
|
|
|||||
Other
|
3,870
|
|
|
1,557
|
|
|
5,427
|
|
|
(486
|
)
|
|
4,941
|
|
|||||
Corporate
|
2,267
|
|
|
5,391
|
|
|
7,658
|
|
|
971
|
|
|
8,629
|
|
|||||
Total fiscal year 2016
|
$
|
13,133
|
|
|
$
|
11,606
|
|
|
$
|
24,739
|
|
|
$
|
485
|
|
|
$
|
25,224
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
Cost of professional services and hosting
|
$
|
31,299
|
|
|
$
|
28,962
|
|
|
$
|
31,054
|
|
Cost of product and licensing
|
816
|
|
|
348
|
|
|
376
|
|
|||
Cost of maintenance and support
|
5,126
|
|
|
3,767
|
|
|
4,138
|
|
|||
Research and development
|
40,087
|
|
|
33,061
|
|
|
35,671
|
|
|||
Sales and marketing
|
39,656
|
|
|
45,813
|
|
|
49,064
|
|
|||
General and administrative
|
33,801
|
|
|
42,321
|
|
|
43,525
|
|
|||
Total
|
$
|
150,785
|
|
|
$
|
154,272
|
|
|
$
|
163,828
|
|
|
Number of
Shares
|
|
Weighted
Average
Exercise
Price
|
|
Weighted
Average
Remaining
Contractual
Term
|
|
Aggregate
Intrinsic
Value
(a)
|
|||||
Outstanding at September 30, 2015
|
2,923,989
|
|
|
$
|
14.01
|
|
|
|
|
|
|
|
Granted
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
Exercised
|
(955,060
|
)
|
|
$
|
11.96
|
|
|
|
|
|
|
|
Forfeited
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
Expired
|
(3,103
|
)
|
|
$
|
10.42
|
|
|
|
|
|
|
|
Outstanding at September 30, 2016
|
1,965,826
|
|
|
$
|
15.01
|
|
|
|
|
|
|
|
Granted
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
Exercised/Repurchased
(b)
|
(1,932,286
|
)
|
|
$
|
14.98
|
|
|
|
|
|
|
|
Forfeited
|
—
|
|
|
$
|
—
|
|
|
|
|
|
|
|
Expired
|
(9,733
|
)
|
|
$
|
20.01
|
|
|
|
|
|
|
|
Outstanding at September 30, 2017
|
23,807
|
|
|
$
|
15.39
|
|
|
|
|
|
||
Granted
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
Exercised
|
(2,963
|
)
|
|
$
|
2.61
|
|
|
|
|
|
||
Forfeited
|
—
|
|
|
$
|
—
|
|
|
|
|
|
||
Expired
|
(1,700
|
)
|
|
$
|
15.99
|
|
|
|
|
|
||
Outstanding at September 30, 2018
|
19,144
|
|
|
$
|
17.31
|
|
|
3.1 years
|
|
$
|
0.1
|
million
|
Exercisable at September 30, 2018
|
19,144
|
|
|
$
|
17.31
|
|
|
3.1 years
|
|
$
|
0.1
|
million
|
Exercisable at September 30, 2017
|
23,798
|
|
|
|
|
|
|
|
|
|
||
Exercisable at September 30, 2016
|
1,965,817
|
|
|
|
|
|
|
|
|
|
(a)
|
The aggregate intrinsic value represents any excess of the closing price of our common stock of
$17.32
on
September 30, 2018
over the exercise price of the underlying options.
|
(b)
|
We repurchased
1.0 million
shares owned directly or indirectly by our Chief Executive Officer, including
649,649
outstanding shares and
800,000
vested stock options with a net share equivalent of
350,351
shares, for an aggregate purchase price of
$21.4 million
.
|
|
2018
|
|
2017
|
|
2016
|
||||||
Total intrinsic value of stock options exercised (in millions)
|
$
|
0.04
|
|
|
$
|
3.59
|
|
|
$
|
8.63
|
|
|
Number of Shares
Underlying Restricted Units — Contingent Awards |
|
Number of Shares
Underlying Restricted Units — Time-Based Awards |
||
Outstanding at September 30, 2015
|
4,700,210
|
|
|
7,007,839
|
|
Granted
|
2,533,389
|
|
|
7,146,415
|
|
Earned/released
|
(2,254,445
|
)
|
|
(7,243,615
|
)
|
Forfeited
|
(754,666
|
)
|
|
(1,026,616
|
)
|
Outstanding at September 30, 2016
|
4,224,488
|
|
|
5,884,023
|
|
Granted
|
3,224,696
|
|
|
8,457,761
|
|
Earned/released
|
(1,790,514
|
)
|
|
(7,150,783
|
)
|
Forfeited
|
(614,739
|
)
|
|
(713,837
|
)
|
Outstanding at September 30, 2017
|
5,043,931
|
|
|
6,477,164
|
|
Granted
|
2,175,537
|
|
|
8,876,712
|
|
Earned/released
|
(2,092,862
|
)
|
|
(7,156,468
|
)
|
Forfeited
|
(2,087,038
|
)
|
|
(1,325,321
|
)
|
Outstanding at September 30, 2018
|
3,039,568
|
|
|
6,872,087
|
|
Weighted average remaining recognition period of outstanding Restricted Units
|
1.0 year
|
|
|
2.2 years
|
|
Unrecognized stock-based compensation expense of outstanding Restricted Units
|
$33.1 million
|
|
$82.3 million
|
||
Aggregate intrinsic value of outstanding Restricted Units
(1)
|
$52.6 million
|
|
$119.1 million
|
(1)
|
The aggregate intrinsic value represents any excess of the closing price of our common stock of
$17.32
on
September 30, 2018
over the exercise price of the underlying Restricted Units.
|
|
2018
|
|
2017
|
|
2016
|
||||||
Weighted-average grant-date fair value per share
|
$
|
15.47
|
|
|
$
|
16.31
|
|
|
$
|
18.93
|
|
Total intrinsic value of shares vested (in millions)
|
$
|
146.5
|
|
|
$
|
146.0
|
|
|
$
|
179.7
|
|
|
Number of
Shares
Underlying
Restricted Stock
|
|
Weighted
Average Grant
Date Fair
Value
|
|||
Outstanding at September 30, 2015
|
250,000
|
|
|
$
|
15.71
|
|
Granted
|
—
|
|
|
$
|
—
|
|
Vested
|
(250,000
|
)
|
|
$
|
15.71
|
|
Outstanding at September 30, 2016
|
—
|
|
|
$
|
—
|
|
Granted
|
250,000
|
|
|
$
|
15.55
|
|
Vested
|
(250,000
|
)
|
|
$
|
15.55
|
|
Outstanding at September 30, 2017
|
—
|
|
|
$
|
—
|
|
Granted
|
—
|
|
|
$
|
—
|
|
Vested
|
—
|
|
|
$
|
—
|
|
Outstanding at September 30, 2018
|
—
|
|
|
$
|
—
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
Weighted-average grant-date fair value per share
|
$
|
—
|
|
|
$
|
15.55
|
|
|
$
|
—
|
|
Total intrinsic value of shares vested (in millions)
|
$
|
—
|
|
|
$
|
3.9
|
|
|
$
|
4.3
|
|
|
2018
|
|
2017
|
|
2016
|
||||||
Weighted-average grant-date fair value per share
|
$
|
4.00
|
|
|
$
|
3.84
|
|
|
$
|
3.97
|
|
Total shares issued (in millions)
|
1.3
|
|
|
1.3
|
|
|
1.2
|
|
|||
Total stock-based compensation expense (in millions)
|
$
|
5.2
|
|
|
$
|
4.9
|
|
|
$
|
4.8
|
|
|
2018
|
|
2017
|
|
2016
|
|||
Dividend yield
|
0.0
|
%
|
|
0.0
|
%
|
|
0.0
|
%
|
Expected volatility
|
32.1
|
%
|
|
29.3
|
%
|
|
34.0
|
%
|
Average risk-free interest rate
|
2.0
|
%
|
|
0.9
|
%
|
|
0.5
|
%
|
Expected term (in years)
|
0.5
|
|
|
0.5
|
|
|
0.5
|
|
Year Ending September 30,
|
|
Operating Leases
|
|
Operating leases under restructuring
|
|
Total
|
||||||
2019
|
|
$
|
29,119
|
|
|
$
|
10,128
|
|
|
$
|
39,247
|
|
2020
|
|
21,299
|
|
|
9,359
|
|
|
30,658
|
|
|||
2021
|
|
18,216
|
|
|
8,536
|
|
|
26,752
|
|
|||
2022
|
|
16,449
|
|
|
8,456
|
|
|
24,905
|
|
|||
2023
|
|
15,572
|
|
|
8,734
|
|
|
24,306
|
|
|||
Thereafter
|
|
64,310
|
|
|
15,663
|
|
|
79,973
|
|
|||
Total
|
|
$
|
164,965
|
|
|
$
|
60,876
|
|
|
$
|
225,841
|
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Domestic
|
$
|
(187,616
|
)
|
|
$
|
(228,406
|
)
|
|
$
|
(118,410
|
)
|
Foreign
|
(29,119
|
)
|
|
109,391
|
|
|
120,149
|
|
|||
(Loss) income before income taxes
|
$
|
(216,735
|
)
|
|
$
|
(119,015
|
)
|
|
$
|
1,739
|
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Current:
|
|
|
|
|
|
|
|
|
|||
Federal
|
$
|
4,189
|
|
|
$
|
—
|
|
|
$
|
—
|
|
State
|
598
|
|
|
2,185
|
|
|
3,230
|
|
|||
Foreign
|
25,623
|
|
|
24,941
|
|
|
22,981
|
|
|||
Total current
|
30,410
|
|
|
27,126
|
|
|
26,211
|
|
|||
Deferred:
|
|
|
|
|
|
|
|
|
|||
Federal
|
(83,319
|
)
|
|
7,291
|
|
|
(7,235
|
)
|
|||
State
|
2,303
|
|
|
1,133
|
|
|
(1,962
|
)
|
|||
Foreign
|
(6,201
|
)
|
|
(3,569
|
)
|
|
(2,817
|
)
|
|||
Total deferred
|
(87,217
|
)
|
|
4,855
|
|
|
(12,014
|
)
|
|||
(Benefit) provision for income taxes
|
$
|
(56,807
|
)
|
|
$
|
31,981
|
|
|
$
|
14,197
|
|
Effective income tax rate
|
26.2
|
%
|
|
(26.9
|
)%
|
|
816.4
|
%
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Federal tax benefit at statutory rate
|
$
|
(53,165
|
)
|
|
$
|
(41,655
|
)
|
|
$
|
609
|
|
State tax provision, net of federal benefit
|
1,698
|
|
|
2,560
|
|
|
137
|
|
|||
Foreign tax rate and other foreign related tax items
|
(13,539
|
)
|
|
(20,415
|
)
|
|
(25,976
|
)
|
|||
Repatriated earnings, net of foreign tax credits
|
—
|
|
|
—
|
|
|
71,343
|
|
|||
Stock-based compensation
|
3,290
|
|
|
6,934
|
|
|
6,154
|
|
|||
Non-deductible expenditures
|
2,546
|
|
|
3,247
|
|
|
3,235
|
|
|||
Change in U.S. and foreign valuation allowance
|
56,557
|
|
|
72,318
|
|
|
(53,079
|
)
|
|||
TCJA impact
|
(87,057
|
)
|
|
—
|
|
|
—
|
|
|||
Goodwill impairment
|
28,640
|
|
|
—
|
|
|
—
|
|
|||
Executive compensation
|
503
|
|
|
5,492
|
|
|
4,749
|
|
|||
Other
|
3,720
|
|
|
3,500
|
|
|
7,025
|
|
|||
(Benefit) provision for income taxes
|
$
|
(56,807
|
)
|
|
$
|
31,981
|
|
|
$
|
14,197
|
|
|
2018
|
|
2017
|
||||
Deferred tax assets:
|
|
|
|
|
|
||
Net operating loss carryforwards
|
$
|
192,017
|
|
|
$
|
269,495
|
|
Federal and state credit carryforwards
|
46,721
|
|
|
58,803
|
|
||
Accrued expenses and other reserves
|
41,371
|
|
|
53,795
|
|
||
Difference in timing of revenue related items
|
81,647
|
|
|
100,971
|
|
||
Deferred compensation
|
19,315
|
|
|
30,528
|
|
||
Other
|
13,802
|
|
|
20,424
|
|
||
Total deferred tax assets
|
394,873
|
|
|
534,016
|
|
||
Valuation allowance for deferred tax assets
|
(183,295
|
)
|
|
(229,449
|
)
|
||
Net deferred tax assets
|
211,578
|
|
|
304,567
|
|
||
Deferred tax liabilities:
|
|
|
|
|
|
||
Depreciation
|
(15,729
|
)
|
|
(36,016
|
)
|
||
Convertible debt
|
(92,452
|
)
|
|
(136,609
|
)
|
||
Acquired intangibles
|
(131,959
|
)
|
|
(221,707
|
)
|
||
Unremitted earnings of foreign subsidiaries
|
—
|
|
|
(20,850
|
)
|
||
Net deferred tax liabilities
|
$
|
(28,562
|
)
|
|
$
|
(110,615
|
)
|
Reported as:
|
|
|
|
|
|
||
Other assets
|
$
|
21,369
|
|
|
$
|
20,705
|
|
Long-term deferred tax liabilities
|
(49,931
|
)
|
|
(131,320
|
)
|
||
Net deferred tax liabilities
|
$
|
(28,562
|
)
|
|
$
|
(110,615
|
)
|
|
September 30,
|
||||||
|
2018
|
|
2017
|
||||
Balance at the beginning of the year
|
$
|
34,058
|
|
|
$
|
31,955
|
|
Increases related to tax positions from prior fiscal years
|
1,720
|
|
|
2,745
|
|
||
Decreases related to tax positions from prior fiscal years
|
(2,281
|
)
|
|
(602
|
)
|
||
Increases for tax positions taken during current period
|
1,709
|
|
|
1,676
|
|
||
Decreases for tax settlements and lapse in statutes
|
(4,083
|
)
|
|
(1,083
|
)
|
||
Cumulative translation adjustments
|
(724
|
)
|
|
(633
|
)
|
||
Balance at the end of the year
|
$
|
30,399
|
|
|
$
|
34,058
|
|
•
|
The Healthcare segment is primarily engaged in providing clinical speech and clinical language understanding solutions that improve the clinical documentation process, from capturing the complete patient record to improving clinical documentation and quality measures for reimbursement.
|
•
|
The Enterprise segment is primarily engaged in using speech, natural language understanding, and artificial intelligence to provide automated customer solutions and services for voice, mobile, web and messaging channels.
|
•
|
The Automotive segment is primarily engaged in providing automotive manufacturers and their suppliers branded and personalized virtual assistants and connected car services built on our voice recognition and natural language understanding technologies.
|
•
|
The Imaging segment is primarily engaged in software solutions and expertise that help professionals and organizations to gain optimal control of their document and information processes through scanning and print management.
|
•
|
Other segment includes our SRS and Devices businesses. Our SRS business provides value-added services to mobile operators in India and Brazil (“Mobile Operator Services”) and voicemail transcription services to mobile operators in the rest of the world (“Voicemail-to-Text”). Our Devices business provides speech recognition solutions and predictive text technologies for handset devices.
|
|
Year Ended September 30,
|
||||||||||
|
2018
|
|
2017
|
|
2016
|
||||||
Segment revenues:
|
|
|
|
|
|
|
|
|
|||
Healthcare
|
$
|
984,819
|
|
|
$
|
899,341
|
|
|
$
|
973,297
|
|
Enterprise
|
483,194
|
|
|
474,317
|
|
|
396,026
|
|
|||
Automotive
|
279,402
|
|
|
252,218
|
|
|
214,267
|
|
|||
Imaging
|
212,903
|
|
|
217,749
|
|
|
241,569
|
|
|||
Other
|
109,064
|
|
|
133,766
|
|
|
154,434
|
|
|||
Total segment revenues
|
2,069,382
|
|
|
1,977,391
|
|
|
1,979,593
|
|
|||
Acquisition related revenue adjustments
(a)
|
(17,721
|
)
|
|
(38,029
|
)
|
|
(30,690
|
)
|
|||
Total consolidated revenue
|
2,051,661
|
|
|
1,939,362
|
|
|
1,948,903
|
|
|||
Segment profit:
|
|
|
|
|
|
|
|
|
|||
Healthcare
|
331,382
|
|
|
262,149
|
|
|
313,466
|
|
|||
Enterprise
|
142,422
|
|
|
135,638
|
|
|
129,259
|
|
|||
Automotive
|
109,867
|
|
|
118,869
|
|
|
95,660
|
|
|||
Imaging
|
67,391
|
|
|
79,512
|
|
|
100,823
|
|
|||
Other
|
28,417
|
|
|
41,568
|
|
|
38,434
|
|
|||
Total segment profit
|
679,479
|
|
|
637,736
|
|
|
677,642
|
|
|||
Corporate expenses and other, net
|
(199,411
|
)
|
|
(125,924
|
)
|
|
(128,239
|
)
|
|||
Acquisition-related revenues and costs of revenues adjustment
|
(17,721
|
)
|
|
(38,029
|
)
|
|
(29,765
|
)
|
|||
Stock-based compensation
|
(150,785
|
)
|
|
(154,272
|
)
|
|
(163,828
|
)
|
|||
Amortization of intangible assets
|
(147,966
|
)
|
|
(178,748
|
)
|
|
(170,897
|
)
|
|||
Acquisition-related costs, net
|
(16,101
|
)
|
|
(27,740
|
)
|
|
(17,166
|
)
|
|||
Restructuring and other charges, net
|
(63,498
|
)
|
|
(61,054
|
)
|
|
(25,224
|
)
|
|||
Impairment of goodwill and other intangible assets
|
(170,941
|
)
|
|
—
|
|
|
—
|
|
|||
Costs associated with IP collaboration agreements
(b)
|
—
|
|
|
—
|
|
|
(4,000
|
)
|
|||
Other expenses, net
|
(129,791
|
)
|
|
(170,984
|
)
|
|
(136,784
|
)
|
|||
(Loss) income before income taxes
|
$
|
(216,735
|
)
|
|
$
|
(119,015
|
)
|
|
$
|
1,739
|
|
(a)
|
Segment revenues differ from reported revenues due to certain revenue adjustments related to acquisitions that would otherwise have been recognized but for the purchase accounting treatment of the business combinations. These revenues are included to allow for more complete comparisons to the financial results of historical operations and in evaluating management performance.
|
(b)
|
We entered into certain collaboration agreements in order to gain access to a third party’s extensive speech recognition technology, natural language technology, and semantic processing technology. Pursuant to these agreements, we had sole rights to commercialize such intellectual property for periods ranging between
two
to
six
years. For fiscal year 2016, we recognized
$4.0 million
as sales and marketing expense for the exclusive commercialization rights related to one of these collaboration agreements in our consolidated statements of operations. No expenses were recognized for fiscal years 2018 and 2017.
|
|
2018
|
|
2017
|
|
2016
|
||||||
United States
|
$
|
1,470,669
|
|
|
$
|
1,352,039
|
|
|
$
|
1,385,265
|
|
International
|
580,992
|
|
|
587,323
|
|
|
563,638
|
|
|||
Total
|
$
|
2,051,661
|
|
|
$
|
1,939,362
|
|
|
$
|
1,948,903
|
|
|
September 30,
2018 |
|
September 30,
2017 |
||||
United States
|
$
|
3,378,698
|
|
|
$
|
3,604,140
|
|
International
|
995,050
|
|
|
999,842
|
|
||
Total
|
$
|
4,373,748
|
|
|
$
|
4,603,982
|
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Fiscal Year
|
||||||||||
2018
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total revenue
|
$
|
501,645
|
|
|
$
|
514,224
|
|
|
$
|
502,887
|
|
|
$
|
532,905
|
|
|
$
|
2,051,661
|
|
Gross profit
|
$
|
280,451
|
|
|
$
|
285,236
|
|
|
$
|
289,449
|
|
|
$
|
322,955
|
|
|
$
|
1,178,091
|
|
Net income (loss)
|
$
|
53,228
|
|
|
$
|
(164,053
|
)
|
|
$
|
(14,037
|
)
|
|
$
|
(35,066
|
)
|
|
$
|
(159,928
|
)
|
Net income (loss) per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
$
|
0.18
|
|
|
$
|
(0.56
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.55
|
)
|
Diluted
|
$
|
0.18
|
|
|
$
|
(0.56
|
)
|
|
$
|
(0.05
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.55
|
)
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
291,367
|
|
|
294,103
|
|
|
292,663
|
|
|
287,052
|
|
|
291,318
|
|
|||||
Diluted
|
295,995
|
|
|
294,103
|
|
|
292,663
|
|
|
287,052
|
|
|
291,318
|
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
|
Fiscal Year
|
||||||||||
2017
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Total revenue
|
$
|
487,658
|
|
|
$
|
499,573
|
|
|
$
|
486,221
|
|
|
$
|
465,910
|
|
|
$
|
1,939,362
|
|
Gross profit
|
$
|
275,248
|
|
|
$
|
286,155
|
|
|
$
|
270,008
|
|
|
$
|
254,151
|
|
|
$
|
1,085,562
|
|
Net loss
|
$
|
(23,929
|
)
|
|
$
|
(33,808
|
)
|
|
$
|
(27,836
|
)
|
|
$
|
(65,423
|
)
|
|
$
|
(150,996
|
)
|
Net loss per share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
$
|
(0.08
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.23
|
)
|
|
$
|
(0.52
|
)
|
Diluted
|
$
|
(0.08
|
)
|
|
$
|
(0.12
|
)
|
|
$
|
(0.10
|
)
|
|
$
|
(0.23
|
)
|
|
$
|
(0.52
|
)
|
Weighted average common shares outstanding:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||
Basic
|
288,953
|
|
|
291,021
|
|
|
287,856
|
|
|
288,718
|
|
|
289,348
|
|
|||||
Diluted
|
288,953
|
|
|
291,021
|
|
|
287,856
|
|
|
288,718
|
|
|
289,348
|
|
Item 9.
|
Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
|
•
|
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
|
•
|
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and,
|
•
|
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.
|
Item 9B.
|
Other Information
|
Item 10.
|
Directors, Executive Officers and Corporate Governance
|
Item 11.
|
Executive Compensation
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholders Matters
|
Item 13.
|
Certain Relationships and Related Transactions, and Director Independence
|
Item 14.
|
Principal Accountant Fees and Services
|
Item 15.
|
Exhibits and Financial Statement Schedules
|
(a)
|
The following documents are filed as a part of this Report:
|
(1)
|
Financial Statements — See Index to Financial Statements in Item 8 of this Report.
|
(2)
|
Financial Statement Schedules — All schedules have been omitted as the requested information is inapplicable or the information is presented in the financial statements or related notes included as part of this Report.
|
(3)
|
Exhibits — See Item 15(b) of this Report below.
|
(b)
|
Exhibits.
|
|
|
|
|
Incorporated by Reference
|
||||||||
Exhibit Index #
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
3.1
|
|
|
10-Q
|
|
0-27038
|
|
3.2
|
|
5/11/2001
|
|
|
|
3.2
|
|
|
10-Q
|
|
0-27038
|
|
3.1
|
|
8/9/2004
|
|
|
|
3.3
|
|
|
8-K
|
|
0-27038
|
|
3.1
|
|
10/19/2005
|
|
|
|
3.4
|
|
|
8-K
|
|
0-27038
|
|
3.1
|
|
11/9/2018
|
|
X
|
|
3.5
|
|
|
S-3
|
|
333-142182
|
|
3.3
|
|
4/18/2007
|
|
|
|
3.6
|
|
|
8-K
|
|
0-27038
|
|
3.1
|
|
8/20/2013
|
|
|
|
|
|
|
Incorporated by Reference
|
||||||||
Exhibit Index #
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
3.7
|
|
|
8-K
|
|
0-27038
|
|
3.2
|
|
8/20/2013
|
|
|
|
4.1
|
|
Specimen Common Stock Certificate.
|
|
8-A
|
|
0-27038
|
|
4.1
|
|
12/6/1995
|
|
|
4.2
|
|
|
8-K
|
|
0-27038
|
|
4.1
|
|
10/24/2011
|
|
|
|
4.3
|
|
|
8-K
|
|
0-27038
|
|
4.1
|
|
8/14/2012
|
|
|
|
4.4
|
|
|
8-K
|
|
0-27038
|
|
4.1
|
|
8/20/2013
|
|
|
|
4.5
|
|
|
8-K
|
|
001-36056
|
|
4.2
|
|
8/18/2014
|
|
|
|
4.6
|
|
|
8-K
|
|
001-36056
|
|
4.1
|
|
6/22/2015
|
|
|
|
4.7
|
|
|
8-K
|
|
001-36056
|
|
4.1
|
|
12/7/2015
|
|
|
|
4.8
|
|
|
8-K
|
|
001-36056
|
|
4.1
|
|
6/22/2016
|
|
|
|
10.1
|
|
|
S-8
|
|
333-108767
|
|
|
|
5/10/2018
|
|
|
|
10.2
|
|
|
S-8
|
|
001-36056
|
|
4.2
|
|
2/6/2015
|
|
|
|
10.3
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
3/6/2018
|
|
|
|
10.4
|
|
|
10-K/A
|
|
0-27038
|
|
10.17
|
|
12/15/2006
|
|
|
|
10.5
|
|
|
10-K/A
|
|
0-27038
|
|
10.18
|
|
12/15/2006
|
|
|
|
10.6
|
|
|
10-K/A
|
|
0-27038
|
|
10.19
|
|
12/15/2006
|
|
|
|
10.7
|
|
|
10-Q
|
|
001-36056
|
|
10.3
|
|
8/9/2018
|
|
|
|
10.8
|
|
|
8-K
|
|
0-27038
|
|
10.1
|
|
11/17/2016
|
|
|
|
10.9
|
|
|
10-K
|
|
001-36056
|
|
10.9
|
|
11/22/2016
|
|
|
|
10.10
|
|
|
10-Q
|
|
001-36056
|
|
10.2
|
|
8/9/2018
|
|
|
|
|
|
|
Incorporated by Reference
|
||||||||
Exhibit Index #
|
|
Exhibit Description
|
|
Form
|
|
File No.
|
|
Exhibit
|
|
Filing Date
|
|
Filed Herewith
|
10.11
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
12/2/2015
|
|
|
|
10.12
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
4/19/2016
|
|
|
|
10.13
|
|
|
8-K
|
|
001-36056
|
|
10.2
|
|
4/19/2016
|
|
|
|
10.14
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
6/17/2016
|
|
|
|
10.15
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
9/7/2016
|
|
|
|
10.16
|
|
|
|
|
|
|
|
|
|
|
X
|
|
10.17
|
|
|
8-K
|
|
001-36056
|
|
10.1
|
|
3/22/2018
|
|
|
|
10.18
|
|
|
8-K
|
|
001-36056
|
|
2.1
|
|
11/14/2018
|
|
|
|
14.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
21.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
23.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
24.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
31.2
|
|
|
|
|
|
|
|
|
|
|
X
|
|
32.1
|
|
|
|
|
|
|
|
|
|
|
X
|
|
101
|
|
The following materials from Nuance Communications, Inc.’s Annual Report on Form 10-K for the fiscal year ended September 30, 2018, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Loss, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows, and (v) Notes to Unaudited Condensed Consolidated Financial Statements.
|
|
|
|
|
|
|
|
|
|
|
*
|
|
Denotes management compensation plan or arrangement
|
|
NUANCE COMMUNICATIONS, INC.
|
|
|
|
|
|
By:
|
/s/ Mark Benjamin
|
|
|
Mark Benjamin
|
|
|
Chief Executive Officer
|
|
|
/s/ Mark Benjamin
|
Date: 11/20/2018
|
|
Mark Benjamin, Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
|
/s/ Daniel D. Tempesta
|
Date: 11/20/2018
|
|
Daniel D. Tempesta
Executive Vice President and Chief Financial Officer (Principal Financial Officer)
|
|
|
|
|
|
/s/ Arthur Giterman
|
Date: 11/20/2018
|
|
Arthur Giterman
Senior Vice President, Chief Accounting Officer and Corporate Controller (Principal Accounting Officer)
|
|
|
|
|
|
/s/ Daniel J. Brennan
|
Date: 11/20/2018
|
|
Daniel J. Brennan, Director
|
|
|
|
|
|
/s/ Laura S. Kaiser
|
Date: 11/20/2018
|
|
Laura S. Kaiser, Director
|
|
|
|
|
|
/s/ Lloyd A. Carney
|
Date: 11/20/2018
|
|
Lloyd A. Carney, Chairman of the Board
|
|
|
|
|
|
/s/ Mark R. Laret
|
Date: 11/20/2018
|
|
Mark R. Laret, Director
|
|
|
|
|
|
/s/ Michal Katz
|
Date: 11/20/2018
|
|
Michal Katz, Director
|
|
|
|
|
|
/s/ Robert J, Finocchio, Jr
|
Date: 11/20/2018
|
|
Robert J, Finocchio, Jr., Director
|
|
|
|
|
|
/s/ Sanjay N. Vaswani
|
Date: 11/20/2018
|
|
Sanjay N. Vaswani, Director
|
|
|
|
|
|
/s/ Thomas D. Ebling
|
Date: 11/20/2018
|
|
Thomas D. Ebling, Director
|
Item 16.
|
Form 10-K Summary
|
|
Page
|
|
ARTICLE I OFFICES
|
1
|
|
ARTICLE II MEETINGS OF STOCKHOLDERS
|
1
|
|
ARTICLE III DIRECTORS
|
11
|
|
MEETINGS OF THE BOARD OF DIRECTORS
|
12
|
|
COMMITTEES OF DIRECTORS
|
13
|
|
COMPENSATION OF DIRECTORS
|
13
|
|
REMOVAL OF DIRECTORS
|
14
|
|
ARTICLE IV NOTICES
|
14
|
|
ARTICLE V OFFICERS
|
14
|
|
THE CHAIRMAN OF THE BOARD
|
15
|
|
THE CHIEF EXECUTIVE OFFICER, PRESIDENT AND VICE-
|
|
|
PRESIDENTS
|
15
|
|
THE SECRETARY AND ASSISTANT SECRETARY
|
15
|
|
THE TREASURER AND ASSISTANT TREASURERS
|
16
|
|
ARTICLE VI CERTIFICATE OF STOCK
|
16
|
|
LOST CERTIFICATES
|
17
|
|
TRANSFER OF STOCK
|
17
|
|
FIXING RECORD DATE
|
18
|
|
REGISTERED STOCKHOLDERS
|
18
|
|
ARTICLE VII GENERAL PROVISIONS
|
18
|
|
DIVIDENDS
|
18
|
|
CHECKS
|
18
|
|
FISCAL YEAR
|
19
|
|
SEAL
|
19
|
|
INDEMNIFICATION
|
19
|
|
PROHIBITION ON TOXICS
|
20
|
|
ARTICLE VIII AMENDMENTS
|
21
|
|
•
|
Honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;
|
•
|
Avoidance of conflicts of interest, including disclosure to an appropriate person or persons identified in this Code of any transaction or relationship that reasonably could be expected to give rise to such a conflict;
|
•
|
Full, fair, accurate, timely, and understandable disclosure in reports and documents that the Company files with, or submits to, the United States Securities and Exchange Commission (the "SEC") and in other public communications made by the Company;
|
•
|
Compliance with applicable governmental laws, rules and regulations;
|
•
|
Adherence to all Nuance policies, including but not limited to Foreign Corrupt Trade Practices and Insider Trading policies;
|
•
|
The prompt internal reporting to an appropriate person or persons identified in this Code of violations of this Code; and
|
•
|
Accountability for adherence to this Code.
|
•
|
Contact the General Counsel by telephone (781-565-5000) or by e-mail
( GeneralCounsel@nuance.com) . |
•
|
Contact the Audit Committee of the Company Board of Directors via Ethicspoint
|
•
|
Contact
Ethicspoint
by Internet
(
www.ethicspoint.com)
or by telephone (1-866-ethicsp (384-4277))
|
|
|
|
|
|
|
|
|
|
|
Subsidiary Name
|
|
Jurisdiction
|
|
Type
|
|||||
|
|
|
|
|
|
|
|
|
|
Agnitio Corp.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
ART Advanced Recognition Technologies, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Caere Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Cognition Technologies, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Consolidated Enterprise Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Consolidated Healthcare Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Consolidated Imaging Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Consolidated Mobile Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Dictaphone Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Ditech Networks, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Ditech Networks International, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
eCopy, LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
iScribes Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
eScription, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Language and Computing, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Montage Healthcare Solutions, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Notable Solutions, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Nuance Diagnostics Holding, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Nuance Transcription Services, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
PerSay, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Phonetic Systems, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Primordial Design, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Quadramed Quantim Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Ruetli Holding Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
SNAPin Software, LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
SVOX USA, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
TouchCommerce, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Viecore Federal Systems Division, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Viecore, LLC
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
VirtuOz, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Vlingo Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
VoiceBox Technologies Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Voice Signal Technologies, Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Zi Holding Corporation
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
Nuance Document Imaging, Inc. f/k/a
Equitrac Corporation |
|
|
Florida
|
|
|
|
Domestic
|
|
|
J.A. Thomas and Associates, Inc.
|
|
|
Georgia
|
|
|
|
Domestic
|
|
|
Nuance Healthcare Diagnostics Solutions, Inc.
|
|
|
Georgia
|
|
|
|
Domestic
|
|
|
Winscribe USA Inc.
|
|
|
Delaware
|
|
|
|
Domestic
|
|
|
AMS Solutions Corp.
|
|
|
Massachusetts
|
|
|
|
Domestic
|
|
|
New England Medical Transcription, Inc.
|
|
|
Illinois
|
|
|
|
Domestic
|
|
|
Accentus U.S., Inc. f/k/a Zylomed Inc.
|
|
|
Nevada
|
|
|
|
Domestic
|
|
|
Medical Transcription Education Center, Inc.
|
|
|
Ohio
|
|
|
|
Domestic
|
|
|
Physician Technology Partners, LLC
|
|
|
Ohio
|
|
|
|
Domestic
|
|
|
Swype, Inc.
|
|
|
Washington
|
|
|
|
Domestic
|
|
|
Tegic Communications, Inc.
|
|
|
Washington
|
|
|
|
Domestic
|
|
|
Nuance Enterprise Solutions & Services Corporation f/k/a Varolii Corporation
|
|
|
Washington
|
|
|
|
Domestic
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary Name
|
|
Jurisdiction
|
|
Type
|
|||||
|
|
|
|
|
|
|
|
|
|
Information Technologies Australia Pty Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
|
ITA Services Pty Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
|
Nuance Communications Australia Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
|
OTE Pty Limited
|
|
|
Australia
|
|
|
|
International
|
|
|
VoiceBox Technologies Australia Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
|
Winscribe Australasia Pty. Ltd.
|
|
|
Australia
|
|
|
|
International
|
|
|
Nuance Communications Austria GmbH
|
|
|
Austria
|
|
|
|
International
|
|
|
Nuance Communications Services Austria GmbH
|
|
|
Austria
|
|
|
|
International
|
|
|
SpeechMagic Holding GmbH
|
|
|
Austria
|
|
|
|
International
|
|
|
Language and Computing N.V.
|
|
|
Belgium
|
|
|
|
International
|
|
|
Nuance Communications Belgium Limited
|
|
|
Belgium
|
|
|
|
International
|
|
|
Nuance Communications International BVBA
|
|
|
Belgium
|
|
|
|
International
|
|
|
Nuance Bermuda Automotive, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
|
Nuance Bermuda Enterprise, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
|
Nuance Bermuda Healthcare, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
|
Nuance Bermuda Imaging, Ltd.
|
|
|
Bermuda
|
|
|
|
International
|
|
|
Nuance Communications Ltda.
|
|
|
Brazil
|
|
|
|
International
|
|
|
Novitech Technologia e Servicos Ltda.
|
|
|
Brazil
|
|
|
|
International
|
|
|
BlueStar Options Inc.
|
|
|
British Virgin Islands
|
|
|
|
International
|
|
|
BlueStar Resources Ltd.
|
|
|
British Virgin Islands
|
|
|
|
International
|
|
|
SpeechWorks BVI Ltd.
|
|
|
British Virgin Islands
|
|
|
|
International
|
|
|
845162 Alberta Ltd.
|
|
|
Canada
|
|
|
|
International
|
|
|
Accentus Inc. f/k/a/ 2350111 Ontario Inc.
|
|
|
Canada
|
|
|
|
International
|
|
|
Ditech Networks Canada, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
|
Nuance Acquisition ULC
|
|
|
Canada
|
|
|
|
International
|
|
|
Nuance Communications Auto, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
|
Nuance Communications Canada, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
|
Nuance Document Imaging, ULC f/k/a Equitrac Canada ULC
|
|
|
Canada
|
|
|
|
International
|
|
|
Zi Corporation
|
|
|
Canada
|
|
|
|
International
|
|
|
Zi Corporation of Canada, Inc.
|
|
|
Canada
|
|
|
|
International
|
|
|
Foxtrot Acquisition Limited
|
|
|
Cayman Islands
|
|
|
|
International
|
|
|
Foxtrot Acquisition II Limited
|
|
|
Cayman Islands
|
|
|
|
International
|
|
|
Huayu Zi Software Technology (Beijing) Co., Ltd.
|
|
|
China
|
|
|
|
International
|
|
|
Nuance Software Technology (Beijing) Co., Ltd.
|
|
|
China
|
|
|
|
International
|
|
|
Nuance Communications Technology Shanghai Ltd
|
|
|
China
|
|
|
|
International
|
|
|
Nuance Communications Denmark ApS
|
|
|
Denmark
|
|
|
|
International
|
|
|
Nuance Communications Finland OY
|
|
|
Finland
|
|
|
|
International
|
|
|
Voice Signal Technologies Europe OY
|
|
|
Finland
|
|
|
|
International
|
|
|
Nuance Communications France Sarl
|
|
|
France
|
|
|
|
International
|
|
|
VirtuOz S.A.
|
|
|
France
|
|
|
|
International
|
|
|
VoiceBox Technologies France SAS
|
|
|
France
|
|
|
|
International
|
|
|
Communology GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
HFN Medien GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
Nuance Communications Deutschland GmbH f/k/a Dictaphone Deutschland GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
Nuance Communications Germany GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
Nuance Communications Healthcare Germany GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary Name
|
|
Jurisdiction
|
|
Type
|
|||||
|
|
|
|
|
|
|
|
|
|
NSi Europe GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
SVOX Deutschland GmbH
|
|
|
Germany
|
|
|
|
International
|
|
|
Asia Translation & Telecommunications Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
|
Huayu Zi Software Technology Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
|
Nuance Communications Hong Kong Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
|
Telecom Technology Corporation Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
|
Zi Corporation (H.K.) Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
|
Zi Corporation of Hong Kong Limited
|
|
|
Hong Kong SAR
|
|
|
|
International
|
|
|
Nuance Recognita Corp.
|
|
|
Hungary
|
|
|
|
International
|
|
|
Ditech Communications India Pvt. Ltd.
|
|
|
India
|
|
|
|
International
|
|
|
Nuance India Pvt. Ltd.
|
|
|
India
|
|
|
|
International
|
|
|
Nuance Transcription Services India Private Limited f/k/a/ FocusMT India Private Limited
|
|
|
India
|
|
|
|
International
|
|
|
ServTech Systems India Pvt. Ltd.
|
|
|
India
|
|
|
|
International
|
|
|
Transcend India Private Limited
|
|
|
India
|
|
|
|
International
|
|
|
Transcend MT Services Private Ltd.
|
|
|
India
|
|
|
|
International
|
|
|
Nuance Communications Services (India) LLP
|
|
|
India
|
|
|
|
International
|
|
|
mCarbon Tech Innovation PVT Ltd.
|
|
|
India
|
|
|
|
International
|
|
|
Terra Firma Services Private LTD
|
|
|
India
|
|
|
|
International
|
|
|
Nuance Communications International Holdings ULC
|
|
|
Ireland
|
|
|
|
International
|
|
|
Nuance Communications Ireland Limited
|
|
|
Ireland
|
|
|
|
International
|
|
|
Nuance Communications Services Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
|
Diamond Auto Technologies Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
|
Diamond Auto Technologies Services Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
|
Nuance Communications Healthcare International Ltd formally Voice Signal Ireland Ltd.
|
|
|
Ireland
|
|
|
|
International
|
|
|
Nuance Communications Israel, Ltd. f/k/a ART-Advanced Recognition Technologies Limited
|
|
|
Israel
|
|
|
|
International
|
|
|
PerSay Ltd.
|
|
|
Israel
|
|
|
|
International
|
|
|
Phonetic Systems Ltd.
|
|
|
Israel
|
|
|
|
International
|
|
|
Loquendo S.p.a.
|
|
|
Italy
|
|
|
|
International
|
|
|
Nuance Communications Italy Srl
|
|
|
Italy
|
|
|
|
International
|
|
|
Nuance Communications Japan K.K.
|
|
|
Japan
|
|
|
|
International
|
|
|
VoiceSignal Japan K.K.
|
|
|
Japan
|
|
|
|
International
|
|
|
Caere Corporation Branch Mexico
|
|
|
Mexico
|
|
|
|
International
|
|
|
Nuance Communications Netherlands B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
|
X-Solutions Group B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
|
Winscribe Inc Ltd.
|
|
|
New Zealand
|
|
|
|
International
|
|
|
VoiceBox Technologies Europe B.V.
|
|
|
Netherlands
|
|
|
|
International
|
|
|
Heartland Asia (Mauritius) Ltd.
|
|
|
Republic of Mauritius
|
|
|
|
International
|
|
|
Nuance Communications Asia Pacific Pte. Ltd.
|
|
|
Singapore
|
|
|
|
International
|
|
|
Nuance Communications Korea Ltd.
|
|
|
South Korea
|
|
|
|
International
|
|
|
Nuance Communications Iberica SA
|
|
|
Spain
|
|
|
|
International
|
|
|
Agnitio S.L.
|
|
|
|
|
|
|
|
|
|
Nuance Communications Sweden, A.B.
|
|
|
Sweden
|
|
|
|
International
|
|
|
Nuance Communications Switzerland AG
|
|
|
Switzerland
|
|
|
|
International
|
|
|
SVOX AG
|
|
|
Switzerland
|
|
|
|
International
|
|
|
Winscribe GmbH
|
|
|
Switzerland
|
|
|
|
International
|
|
|
|
|
|
|
|
|
|
|
|
Subsidiary Name
|
|
Jurisdiction
|
|
Type
|
|||||
|
|
|
|
|
|
|
|
|
|
Nuance Communications Taiwan
|
|
|
Taiwan
|
|
|
|
International
|
|
|
Nuance Communications Illetism Ltd. Sirketi
|
|
|
Turkey
|
|
|
|
International
|
|
|
Nuance Turkey Iletisim Hizmetleri Ltd. Sirketi
|
|
|
Turkey
|
|
|
|
International
|
|
|
Nuance Communications UK Limited
|
|
|
United Kingdom
|
|
|
|
International
|
|
|
SpinVox Limited
|
|
|
United Kingdom
|
|
|
|
International
|
|
|
Winscribe Europe Ltd.
|
|
|
United Kingdom
|
|
|
|
International
|
|
|
TouchCommerce UK Ltd.
|
|
|
United Kingdom
|
|
|
|
International
|
|
|
Mcarbon Tech Innovation Middle East -FX- LLC
|
|
|
UAE
|
|
|
|
International
|
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
|
|
By:
|
|
/s/ Mark Benjamin
|
|
|
|
Mark Benjamin
|
|
|
|
Chief Executive Officer
|
a.
|
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
a.
|
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.
|
|
By:
|
|
/s/Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
By:
|
|
/s/ Mark Benjamin
|
|
|
|
Mark Benjamin
|
|
|
|
Chief Executive Officer
|
|
By:
|
|
/s/Daniel D. Tempesta
|
|
|
|
Daniel D. Tempesta
|
|
|
|
Executive Vice President and Chief Financial Officer
|